buy table gefunden in Unterhaltung
✖ 
Produkt merken 
zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste ![]()
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste 
Produkt merken zur Merkliste CHF 239.00
National Forest Inventories
Title: National Forest Inventories - Assessment of Wood Availability and Use (467 pages)Editors: Adrian Lanz, Iciar Alberdi Asensio, Laura Hernandez, John Redmond, Claude VidalPreliminariesPreface (2 pages)Acknowledgement (1 page)COST information (1 page)Table of Contents (4 pages)Abbreviations (2 pages)List of participants (10 pages)Chapter 1 Introduction (14 pages)1.1 Overview of wo... zur Produkt-Seite
4883243 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvYWUvOTYvNWMvNTg2NTI0MTcwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvYWUvOTYvNWMvNTg2NTI0MTcwMDAwMUFfNjAweDYwMC5qcGc=","post_title":"National Forest Inventories","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319440149&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmathematik%2F450934%2Fnational-forest-inventories-assessment-of-wood-availability-and-use%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Title: National Forest Inventories - Assessment of Wood Availability and Use (467 pages)Editors: Adrian Lanz, Iciar Alberdi Asensio, Laura Hernandez, John Redmond, Claude VidalPreliminariesPreface (2 pages)Acknowledgement (1 page)COST information (1 page)Table of Contents (4 pages)Abbreviations (2 pages)List of participants (10 pages)Chapter 1 Introduction (14 pages)1.1 Overview of wood resource assessment (3 pages)Development of international reporting from first FRA report to UNFCCC Current information needs on availability of wood resources, including round-wood and bioenergy. Monitoring sustainable forest management and climate change 1.2 Uses of NFI data to estimate potential wood supply (3 pages)1.2.1 National level National models using NFI data to predict the potential wood supply (scenario modelling) 1.2.2 International levelStudies using existing forest resource information for modelling the potential wood supply (e.g. EFISCEN, EFDM and EFSOS) The input data used in these models 1.3 Harmonising wood resource information (2 pages)Reference to the FAO and the ENFIN harmonisation processes Standardisation vs. harmonisation Principles in establishing reference definitions and the process of bridge building 1.4 Objectives and overview of Cost Action FP1001 (3 pages)Reference to the memorandum of understanding The topics and structure of working group 1 (within FP001) Way of working within Working Group 1 (overview of existing references, information needs and current national methods, proposal of common reference definitions in small groups with validation in the large group of experts). 1.5 Structure of the book (1 page)1.6 References (2 pages)Chapter 2. Comparison of Wood Resource Assessment in National Forest Inventories (14 pages)2.1 Materials (4 pages)The mechanism used for collecting information on the current status of wood resource assessment in European NFIs: questionnaires and country reports Four separate online questionnaires covering the sub-task areas of the working group: forest available for wood supply, stem quality and assortments, change estimation, other wooded land and trees outside forest Structure and contents of country reports with detailed information on resource availability and NFI methods from countries 2.2 Diversity in national definitions and in the monitoring of wood resources (8 pages)\u00b7 Analysis and discussion by sub-groups highlighting the diversity (in methods, and natural and economic conditions), but also the similarity and degree of harmonisation between NFI methods2.3 References (2 pages)Chapter 3. Harmonisation of information on the potential supply of wood resources (11 pages)3.1 Introduction (2 pages)\u00b7 FP1001 as a continuation of the process initiated by ENFIN and national experts in Cost Action E43: extension to the monitoring of wood use3.2 Building reference definitions (2 pages)\u00b7 Existing international definitions (FRA, European standards, Forest Europe, etc.)\u00b7Status of national definitionsPrinciple in defining reference definition Proposal and validation by participants \u00a03.3 Reference definitions (4 pages)Reference definitions by sub-group (topic) with explanations 3.4 Summary (1 page)3.5 References (2 pages)Chapter 4. Progresses in the harmonised assessment of availability and use of wood resources (14 pages)4.1 Introduction (1 page)Application and demonstration projects in building harmonised information for EU purposes (EINFIN's framework contract with the European Commission Joint Research Centre) 4.2 Use of the Cost Action reference definition (2 pages)Deviation of current reporting from proposed reference definitions 4.3 Bridges for converting estimates (4 pages)Case studies on the implementation of reference definitions and effects of varying thresholds, e.g. in the definition and classification of trees outside forest with the help of remote sensing data, of the forest land available for wood supply using GIS data, and a cross-country comparison of stem quality assessment systems 4.4 NFI and harmonisation of reporting (2 pages)Prospective in up-taking and implementing the harmonisation process into common international reporting 4.5 Knowledge sharing and future work (3 pages)Impact of ENFIN's harmonisation work on national forest inventories Capacity of countries to further adopt to agreed reference definitions Chapter 5 to approx. 30 Reports from countries (375 pages)The reports are original documents produced by national experts. The reports follow a common structure (see the enclosed template). On average, approx. 15 pages per report. Appendix (15 pages)List of reference definitions (15 pages) Index (4 pages","merchants_number":1,"ean":9783319440149,"category_id":103,"size":null,"min_price":239,"low_price_merchant_id":70255345,"ID":4883243,"merchants":["euniverse"],"brand":"undefined","slug":"national-forest-inventories","url":"\/unterhaltung\/produkt\/national-forest-inventories\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 118.00
Consultation in Neurourology
Table of Contents Foreword(s) Preface Part I INTRODUCTION Chapter 1 Book Presentation with Overview of Bladder Physiology Book Presentation Organization of Summaries and Recommendations Overview of the Physiology of Lower Urinary Tract Chapter 2 Neurogenic Bladder Pathophysiology Introduction Neurogenic Detrusor Overactivity Neurogenic Detrusor Underactivity... zur Produkt-Seite
4163573 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9pLndlbHRiaWxkLmRlL3AvY29uc3VsdGF0aW9uLWluLW5ldXJvdXJvbG9neS0zMjUxNzI2MTAuanBn!aHR0cHM6Ly9pLndlbHRiaWxkLmRlL3AvY29uc3VsdGF0aW9uLWluLW5ldXJvdXJvbG9neS0zMjUxNzI2MTAuanBnfH58aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvOTcvNzMvNmMvNjQ4NTY1NTMwMDAwMUFfNjAweDYwMC5qcGc=","post_title":"Consultation in Neurourology","deeplink":"https:\/\/track.adtraction.com\/t\/t?a=1632201226&as=1592767275&t=2&tk=1&url=https:\/\/www.weltbild.ch\/artikel\/x\/_23215143-1","labels":[],"brand_id":1,"post_content":"Table of Contents Foreword(s) Preface Part I INTRODUCTION Chapter 1 Book Presentation with Overview of Bladder Physiology Book Presentation Organization of Summaries and Recommendations Overview of the Physiology of Lower Urinary Tract Chapter 2 Neurogenic Bladder Pathophysiology Introduction Neurogenic Detrusor Overactivity Neurogenic Detrusor Underactivity Detrusor-Sphincter Dyssynergia Neurogenic Sphincter Deficiency Conclusion Chapter 3 Pathologies Responsible for the Development of the Neurogenic Bladder Introduction Traumatic Entities and their Neuro-Urological Consequences Head Injury Spinal Cord Injury Spinal shock Suprasacral injury Sacral injury Spinal cord injury and bladder behaviour - general overview Non-Traumatic Entities and Their Neuro-Urological Consequences Suprapontine Lesion (Brain) Cerebrovascular accident Degeneration (Parkinsonian syndrome, Dementia) Brain Tumors Cerebral Palsy Infrapontine-Suprasacral Lesion (Spinal Cord) Demyelination (Multiple sclerosis, Transverse myelitis) Spina Bifida Sacral-Infrasacral Lesion (Spinal Cord and Peripheral Nervous System) Intervertebral Disk Prolapse Peripheral Neuropathies (Diabetes, Iatrogenic causes) Conclusion Part II FIRST CONSULTATION OF PATIENTS WITH SPINAL CORD INJURY Chapter 4 Medical History and Physical Examination Introduction Medical History Physical Examination Conclusion Chapter 5 Testing Introduction Recommended Tests Urinalysis\/urine Culture Blood Chemistry Voiding Diary Postvoid Residual Urinary Tract Ultrasound Elective Tests Urethrocystoscopy Computed Tomography, Magnetic Resonance Imaging, Other Uroflowmetry Urodynamic Testing Video-urodynamics Specialist Uro-neurophysiological Tests Conclusion Chapter 6 Bladder Management and Follow-Up Plan Introduction Bladder Management Follow-up Plan Conclusion Part III CONSULTATIONS FOR MAIN COMPLAINTS IN NEUROGENIC BLADDERS Chapter 7 Incontinence Due to Neurogenic Detrusor Overactivity Introduction Epidemiology Diagnosis History and Physical Examination Bladder Diary and Questionnaires Urinalysis and Urine Culture Pad-weighing Test Renal Evaluation Other Investigations Urodynamics Involuntary detrusor contractions Decreased bladder compliance Increased bladder sensation Decreased cystometric capacity Treatment Conservative Treatment Pharmacological Treatment Oral administration Transcutaneous administration Intravesical administration Botulinum Toxin A Injections Neurostimulation\/Neuromodulation Sacral neuromodulation Tibial nerve stimulation Transcutaenous electrical nerve stimulationSurgery Bladder augmentation and detrusor myectomy Urinary diversion Conclusion Chapter 8 Retention Introduction Epidemiology Diagnosis History and Physical Examination Bladder Diary and Questionnaires Urinalysis and Urine Culture Uroflowmetry Postvoid Residual Renal Evaluation Bladder Ultrasound Other Investigations Patients with retention due to neurogenic detrusor underactivity (Detrusor underactivity, Reduced bladder sensation, Increased cystometric capacity) Patients with retention due to detrusor-sphincter dyssynergia Treatment Treatment of Patients with Retention Due to NDU Intermittent catheterization Indwelling catheterization Sacral neuromodulation Other modalities Treatment of Patients with Retention Due to DSD Intermittent catheterization + pharmacotherapy Botulinum toxin A injections Sacral neuromodulation External sphincterotomy Indwelling catheteriation, urinary diversion Special Consideration for Patients With Detrusor Hyperactivity and Impaired Contractility Conclusion Chapter 9 Incontinence Due to Neurogenic Sphincter Deficiency Introduction Epidemiology Diagnosis Medical History Physical Examination Other Recommended and Elective Tests Urodynamics Treatment Conservative Treatment Pelvic floor muscle therapy Surgery Artificial urinary sphincter Slings Bulking agents Artifical compression devices (balloon insertion) Invasive surgery Conclusion Part IV CONSULTATIONS FOR COMPLICATIONS OF NEUROGENIC BLADDER Chapter 10 Urinary Tract Infection Introduction Definitions Epidemiology Diagnosis Symptoms and Signs Laboratory Testing Additional Testing Treatment Prevention Mechanical Strategies for UTI Prevention Intermittent catheterization Indwelling catheterization Medical Strategies for UTI prevention Conclusion Chapter 11 Urolithiasis Introduction Epidemiology Risk Factors Stone Composition Diagnosis and Treatment Diagnosis Treatment Preoperative Considerations in Neurogenic Patents Suffering from Uroliathisis Treatment Options Prevention Conclusion Chapter 12 Hydronephrosis Introduction Pathophysiology Diagnosis Medical History and Physical Examination Laboratory Testing Imaging Ultrasound Computed tomography Other techniques Treatment Drainage Percutaneous nephrostomy Ureteral stents Other Vesicoureteral Reflux Conclusion Chapter 13 Renal Failure Introduction Epidemiology Diagnosis Chronic Kidney Disease (Chronic Renal Failure) Definitions and staging Signs and symptoms Laboratory data Imaging studies Acute Kidney Injury Definitions and staging Signs and symptoms Laboratory data Imaging studies Treatment Treatment of Chronic Kidney Disease Urinary diversion Renal replacement therapy Treatment of Acute Kidney Injury Conclusion Chapter 14 Autonomic Dysreflexia Introduction Pathophysiology Epidemiology Aetiology Diagnosis Symptoms and Signs Consequences Treatment Acute Management Chronic Management (Prevention) Conclusion Chapter 15 Other (Bladder Cancer, Sexual Dysfunction) Bladder cancer EpidemiologyRisk Factors Screening Diagnosis and Treatment Sexual Dysfunction Epidemiology Diagnosis Treatment Management of sexual (erectile) dysfunction in the male Management of sexual dysfunction in the female) Conclusion Chapter 16 Benign Prostatic Hyperplasia and Neurogenic Bladder Introduction Epidemiology Diagnosis Treatment Pharmacological Treatment Surgical Treatment Other Treatment Options Conclusion Part V PATIENT EDUCATION Chapter 17 Patient Education Introduction Intermittent Catheterization Behavioural Techniques Toileting Assistance Pelvic Floor Muscle Therapy Lifestyle Intervention Care of Urinary Diversion Conclusion Part VI REPORTS AND GUIDELINES Chapter 18 Reports and Guidelines on Neurogenic Bladder General Neurourological Guidelines Patients after Spinal Cord Injury Pediatric Patients Urodynamics Regional Guidelines","merchants_number":2,"ean":9783319639093,"category_id":103,"size":null,"min_price":118,"low_price_merchant_id":27291482,"ID":4163573,"merchants":["weltbild","euniverse"],"brand":"undefined","slug":"consultation-in-neurourology","url":"\/unterhaltung\/produkt\/consultation-in-neurourology\/","low_price_merchant_name":"Weltbild"}
Produkt merken zur Merkliste CHF 239.00
The Palgrave Handbook of Intersectionality in Public Policy
TABLE OF CONTENTS 1. Bringing Intersectionality to Public Policy: An IntroductionOlena Hankivsky & Julia Jordan-Zachery PART I: FOUNDATIONS IN THE FIELD 2. How Does One Live the Good Life? Assessing the State of Intersectionality in Public PolicyTiffany Manuel 3. Reflecting on Am I a Black Woman or a Woman Who is Black? A Few Thoughts on the Meaning of IntersectionalityJulia Jordan-... zur Produkt-Seite
4943645 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvMjQvMWQvODMvNzE2NzcwODIwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvMjQvMWQvODMvNzE2NzcwODIwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC90aGUtcGFsZ3JhdmUtaGFuZGJvb2stb2YtaW50ZXJzZWN0aW9uYWxpdHktaW4tcHVibGljLTI4MDc1ODIwNy5qcGc=","post_title":"The Palgrave Handbook of Intersectionality in Public Policy","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319984728&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fsozialwissenschaften-recht-wirtschaft%2Fmedien-kommunikation%2F478072%2Fthe-palgrave-handbook-of-intersectionality-in-public-policy%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"TABLE OF CONTENTS\u00a01. Bringing Intersectionality to Public Policy: An IntroductionOlena Hankivsky & Julia Jordan-Zachery \u00a0PART I: FOUNDATIONS IN THE FIELD\u00a02.\u00a0 How Does One Live the Good Life? Assessing the State of Intersectionality in Public PolicyTiffany Manuel\u00a03. Reflecting on Am I a Black Woman or a Woman Who is Black? A Few Thoughts on the Meaning of IntersectionalityJulia Jordan-Zachery\u00a04. Intersectionality and Public Policy: Some Lessons from Existing ModelsOlena Hankivsky & Renee Cormier\u00a05. Empirical Intersectionality: A Tale of Two ApproachesAnge-Marie Hancock\u00a06. An Intersectionality-Based Policy Analysis Framework: Critical Reflections on a Methodology for Advancing EquityOlena Hankivksy, Daniel Grace, Gemma Hunting, Melissa Giesbrecht, Alycia Fridkin, Sarah Rudrum, Olivier Ferlatte & Natalie Clark\u00a07. The Difference That Power Makes: Intersectionality and Participatory DemocracyPatricia Hill Collins\u00a0PART II:\u00a0 INNOVATIVE METHODOLOGICAL DIRECTIONS AND IMPLICATIONS FOR POLICY ANALYSIS\u00a08. Quantitative Approaches to Intersectionality: New Methodological Directions and Implications for Policy AnalysisJoshua Dubrow & Corina Ilinca\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a09. Cultivating Intersectional Communities of Practice: A Case Study of the New Mexico Statewide Race, Gender, Class Data Policy Consortium As a Convergence Space for Co-Creating Intersectional Inquiry, Ontologies, Data Collection and Social Justice PraxisNancy L\u00f3pez, Michael O'Donnell, Lucas Pedraza, Carmela Roybal & Jeffrey Mitchell\u00a010. Beyond economic barriers: Intersectionality and health policy in low- and middle-income countriesGita Sen & Aditi Iyer\u00a011. Lobbying suicide prevention policy for gay and bisexual men: An intersectionality-informed photovoice project Olivier Ferlatte & John Oliffe\u00a0PART III: DIFFERENT PERSPECTIVES ON PERSISTENT PROBLEMS\u00a012. Understanding Single Womanhood in China: An Intersectional PerspectiveCrystal, L. Jiang & Wanqi Gong\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a013. An Intersectionality Based Framework for Tobacco Control Jenny Douglas\u00a014. \"If they beat you and your children have eaten, that is fine...\" Intersections of Poverty, Livelihoods and Violence against Women and Girls in the Karamoja Region, Uganda Joseph Rujumba & Japheth Kwiringira\u00a015. Through the Looking Glass: An Intersectional Lens of South African Education PolicyMich\u00e8le Schmidt & Raj Mestry\u00a016. Scaling Educational Policy and Practice Intersectionally: Historical and Contemporary Cases from South and Southeast Asia Mayurakshi Chaudhuri, Viola Thimm, & Sarah Mahler\u00a0PART IV: COMMUNITY ENGAGEMENT AND ADVOCACAY FOR CHANGE\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 17. Intersectionality and Indigenous Peoples in Australia: Experiences with engagement in Native Title and mining Natalie Osborne, Catherine Howlett, & Deanna Grant-Smith\u00a018. From gender-sensitivity to an intersectionality and participatory approach in health research and public policy in the NetherlandsPetra Verdonk, Maaike Muntinga, Hannah Leyerzapf & Tineke Abma\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a019. Intersectional Analysis of Age in the Context of Rural Health Policy in UkraineAnna Vorobyova \u00a020. Intersectional Advocacy and Policymaking across U.S. States Kathleen Marchetti\u00a021. Bringing Intersectionality into Danish Public PolicyHeidi Lene Mygleg\u00e5rd Andersen\u00a022. Intersectionality and LGBTI public policies in ColombiaCamila Esguerra Muelle & Jeisson Alanis Bello Ram\u00edrezc\u00a0PART V: CHALLENGING COLONIZATION\u00a023 Decoloniality and Emancipatory Intersectionality: The Political Organizing of Domestic Workers in BrazilJoaze Bernardino-Costa\u00a024. \"Who will use my loom when I am gone?\" An Intersectional Analysis of Mapuche Women's Progress in Twenty-First Century ChileSerena Cosgrove\u00a025. How Intersectionality-based Approaches to International Development Illuminate the Plight of Palestine RefugeesCharla M. Burnett\u00a026. Intersectional Borders in Argentina: Migration, Inequalities and Judicial ColonialismMar\u00eda Jos\u00e9 Magliano & Vanina Ferreccio\u00a027. Hearing or Listening? Pipeline Politics and the Art of Engagement in British ColumbiaSarah Marie Wiebe\u00a0PART VI: RESPONDING TO NEW AND PRESSING CHALLENGES\u00a028. Exploring Intersectionality as a Policy Tool for Gender Based Policy Analysis: Implications for Language and Health Literacy as Key Determinants of IntegrationNancy Clark & Bilkis Vissandj\u00e9e\u00a029. The Significance of Intersectionality in Mental Health Care Policy in South AfricaJacqueline Moodley\u00a030. Aging-in-Place for Low-Income Seniors: Living at the Intersection of Multiple Identities, Positionalities, and OppressionsJudith Sixsmith, Mei Lan Fang, Ryan Woolrych, Sarah Canham, Lupin Battersby, Tori Hui Ren, & Andrew Sixsmith\u00a031. Need and opportunity: Addressing diverse stakeholders and power in the conflict over Toolangi State Forest, Victoria, AustraliaLisa De Kleyn\u00a032. Listening for Intersectionality: How Disabled Persons Organisations have Improved Recognition of Difference in Australia's National Disability Insurance Scheme Cate Thill\u00a033. Are we all 'baskets of characteristics?' Intersectional slippages and the displacement of race in English and Scottish equality policyAshlee Christoffersen\u00a034. Timid Imposition: Intersectional Travel and Affirmative Action in UruguayErica Townsend-Bell","merchants_number":2,"ean":9783319984728,"category_id":103,"size":null,"min_price":239,"low_price_merchant_id":70255345,"ID":4943645,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"the-palgrave-handbook-of-intersectionality-in-public-policy","url":"\/unterhaltung\/produkt\/the-palgrave-handbook-of-intersectionality-in-public-policy\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 143.00
Essentials of Clinical Mycology
REVIEWS OF FIRST EDITION:From the New England Journal of Medicine, June 24, 2004About 40 years ago, when I started seeing patients in my specialty of infectious diseases, systemic fungal infections were relatively uncommon. The literature consisted mostly of case reports and uncontrolled descriptive studies, and little time was given to discussing clinical mycology at national meeting... zur Produkt-Seite
4144172 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvNTUvMzkvNzQvMjUzMjg4NTgwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvNTUvMzkvNzQvMjUzMjg4NTgwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9lc3NlbnRpYWxzLW9mLWNsaW5pY2FsLW15Y29sb2d5LTMyNTc2NDQwNi5qcGc=","post_title":"Essentials of Clinical Mycology","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9781441966391&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmedizin-pharmazie%2F319966%2Fessentials-of-clinical-mycology%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"REVIEWS OF FIRST EDITION:From the New England Journal of Medicine, June 24, 2004About 40 years ago, when I started seeing patients in my specialty of infectious diseases, systemic fungal infections were relatively uncommon. The literature consisted mostly of case reports and uncontrolled descriptive studies, and little time was given to discussing clinical mycology at national meetings. Times have changed. Clinical mycology could almost warrant a subspecialty designation because of the number of patients who are infected, the expansion of literature that deals with the basic mechanism of pathogenesis and virulence of fungal infections, and the number of controlled clinical studies on the topic. Forty years ago, the only drug that was available to treat systemic fungal infections was amphotericin B. In 2004, at least 10 antifungal agents are approved to treat systemic infections (not counting combinations), and more drugs are in the pipeline. (Figure) This relatively recent explosion of literature on mycology clearly needs to be brought together into one sourcebook. Dismukes, Pappas, and Sobel have succeeded in doing this in a splendid fashion. Dismukes and Pappas have been conducting clinical studies on antifungal agents for many years as participants in the Bacteriology and Mycology Study Group, sponsored by the National Institute of Allergy and Infectious Diseases. Dr. Sobel is a leading clinical investigator focusing on candida infections. The three editors have assembled an impressive list of contributors to put together a well-written, informative textbook about all of the important systemic and superficial fungal infections. This book is oriented toward the clinician. The general section on medical mycology is brief, as is the general section on epidemiology. That is probably as it should be in a book that is focused on clinical mycology. The chapter on laboratory aspects of medical mycology would have been helped by a table or a figure summarizing general taxonomy. The excellent section on systemic antifungal drugs is up to date and complete -- and the tables summarizing the options for treatment are particularly helpful. Many of the recommendations are repeated in the chapters on individual mycoses, but repetition is good when it emphasizes important points in diagnosis and therapy. Clinical studies and treatment guidelines for the individual groups of infections are summarized in easy-to-read tables. In every case, the recommendations are reasonable and consistent with the source literature, and the editing is excellent. The section that describes special populations of patients who are highly susceptible to systemic fungal infections emphasizes the book's clinical orientation and answers all the important questions about epidemiology, diagnosis, prophylaxis, and treatment. Minor points to mention are that the chapters dealing with medical mycology and epidemiology are the least useful ones and could be combined. The color photographs of patients with various fungal diseases are excellent but would be more helpful if they were incorporated into the relevant chapters. As I read the book, I wondered whether experts in the field could learn something from it. My answer is yes. Old material is reviewed, and the authors' conclusions and recommendations are reasonable. The book also presents material that was new to me, even in areas in which I have a special interest. This textbook will be very useful to any specialist in infectious diseases or to any physician who cares for immunodeficient patients. It will greatly add to the information covered by standard textbooks on medicine and infectious diseases and will answer many questions that are now the subject of Internet searches. I look forward to using it extensively in my practice. Gerald Medoff, M.D.Copyright \u00a9 2004 Massachusetts Medical Society. All rights reserved. The New England Journal of Medicine is a registered trademark of the MMS.Review\"...this b","merchants_number":2,"ean":9781441966391,"category_id":103,"size":null,"min_price":143,"low_price_merchant_id":70255345,"ID":4144172,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"essentials-of-clinical-mycology","url":"\/unterhaltung\/produkt\/essentials-of-clinical-mycology\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 189.00
Current Management of Venous Diseases
Current Management of Venous Diseases Editor: Cassius Iyad Ochoa Chaar Table of Contents Section I: Clinical Fundamentals Chapter 1 - Venous anatomy, development, and variations - Joann M. Lohr and Nicolas J. Mouawad Chapter 2 - Venous physiology and pathophysiology - James Laredo and Byung Boong Lee Chapter 3 - Diagnostic Imaging for Veins - Fedor Lurie, Jih... zur Produkt-Seite
5024768 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZWYvZmEvZTYvNjUzOTg4MjUwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZWYvZmEvZTYvNjUzOTg4MjUwMDAwMUFfNjAweDYwMC5qcGc=","post_title":"Current Management of Venous Diseases","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319652252&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmedizin-pharmazie%2F463105%2Fcurrent-management-of-venous-diseases%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Current Management of Venous Diseases \u00a0 Editor: Cassius Iyad Ochoa Chaar \u00a0 Table of Contents \u00a0 \u00a0 Section I: Clinical Fundamentals \u00a0 Chapter 1 - Venous anatomy, development, and variations - Joann M. Lohr and Nicolas J. Mouawad \u00a0 Chapter 2 - Venous physiology and pathophysiology - James Laredo and Byung Boong Lee \u00a0 Chapter 3 - Diagnostic Imaging for Veins - Fedor Lurie, Jihad Abbass and John H. Fish, III \u00a0 Chapter 4 - Evaluation of Edema of the Extremity - John H. Fish III and Fedor Lurie \u00a0 Chapter 5 - Compression Therapy in Venous Disease - Robert R. Attaran and Cassius Iyad Ochoa Chaar \u00a0 \u00a0 Section II: Venous Insufficiency \u00a0 Chapter 6 - Clinical presentation of venous insufficiency - Lisa E. Amatangelo and M. Emily Wilcox Cummings \u00a0 Chapter 7 - Open surgical treatment of superficial reflux - Andreas M. Lazaris and George Geroulakos \u00a0 Chapter 8 - Laser Ablation for Venous Reflux - Mikel Sadek and Lowell S. Kabnick Chapter 9 - Radiofrequency Ablation for Lower Extremity Venous Reflux - John Blebea and Zhamak Khorgami \u00a0 Chapter 10 - Mechanochemical ablation of superficial veins - Afsha Aurshina and Cassius Iyad N. Ochoa Chaar Chapter 11 - Endovenous sealing of superficial veins - Roshan Bootan, Tristan R. A. Lane, Ian J. Franklin and Alun H. Davies \u00a0 Chapter 12 - Sclerotherapy - Kathleen Gibson \u00a0 Chapter 13 - Treatment of Incompetent Perforating Veins - Eric S. Hager and Joyce Y. Lin \u00a0 Chapter 14 - Cosmetic approach to varicose veins: the ASVAL technique - Sylvain Chastanet and Paul Pittaluga \u00a0 Chapter 15 - Strategies to treat venous reflux disease - Andrew M. Abi-Chaker, Priscila Gisselle Sanchez Aguirre and Jose I. Almeida \u00a0 Chapter 16 - Complications of the treatment of venous insufficiency - Peter F. Lawrence \u00a0 Chapter 17 - Valve reconstruction for deep venous reflux - Oscar Maleti and Marzia Lugli \u00a0 Chapter 18 - Pelvic venous insufficiency - Olivier Hartung \u00a0 \u00a0 Section III: Acute venous thromboembolism \u00a0 Chapter 19 - Presentation and significance of VTE - Meera Sridharan and Aneel A. Ashrani \u00a0 Chapter 20 - Prevention of venous thromboembolism - Nirvana Sadaghianloo and Alan Dardik \u00a0 Chapter 21 - Overview of anticoagulation agents - Saman Doroodgar Jorshery, Afsha Aurshina and Cassius Iyad Ochoa Chaar \u00a0 Chapter 22 - Superficial thrombophlebitis - Anil Hingorani and Enrico Ascher \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 A: Deep vein thrombosis \u00a0 Chapter 23 - Anticoagulation for proximal DVT - Alfred Ian Lee and Eun-Ju Lee \u00a0 Chapter 24 - Controversies in the diagnosis and management of distal deep vein thrombosis - Helia Robert-Ebadi and Marc Righini \u00a0 Chapter 25 - Endovascular treatment of deep vein thrombosis - Raja S. Ramaswamy and Suresh Vedantham \u00a0 Chapter 26 - Surgical thrombectomy for deep vein thrombosis - Faisal Aziz and Emelia Bittenbinder \u00a0 Chapter 27 - Upper extremity deep vein thrombosis - Suzanne M. Bleker, No\u00e9mie Kraaijpoel and Harry R. B\u00fcller \u00a0 Chapter 28 - Venous thoracic outlet syndrome - Kristine Clodfelter Orion and Julie Ann Freischlag \u00a0 \u00a0 B: Pulmonary Embolism \u00a0 Chapter 29 - Medical management of pulmonary embolism - Stefano Barco and Stavros V. Konstantinides \u00a0 Chapter 30 - Catheter directed Thrombolysis of pulmonary embolism - Adham Abou Ali, Efthymios D. Avgerinos and Rabih A. Chaer Chapter 31 - Surgical management of pulmonary embolism - Jeenah Jung and Pramod Bonde \u00a0 Chapter 32 - Vena cava interruption - John E. Rectenwald \u00a0 Chapter 33 - Retrieval of inferior vena cava filters - Anand Brahmandam, Afsha Aurshina and Cassius Iyad Ochoa Chaar \u00a0 \u00a0 Section IV: Chronic Venous Obstruction \u00a0 Chapter 34 - Wound care management for venous ulcers - Sheena K. Harris, Dale G. Wilson and Robert B. McLafferty \u00a0 Chapter 35 - May-Thurner syndrome: diagnosis and management - Brian DeRubertis and Rhusheet Patel \u00a0 Chapter 36 - Endovascular recanalization of chronic venous obstruction - David L. Gillespie and Micheal Toma Ayad \u00a0 Chapter 37 - The venous stent: Is it primetime yet? - Arjun Yajaraj and Seshadri Raju \u00a0 Chapter 38 - Open reconstruction for chronic venous obstruction - Arjun Yajaraj and Peter Gloviczki \u00a0 Chapter 39 - Hybrid reconstruction for post-thrombotic iliofemoral venous obstruction - Anthony J. Comerota and Zakaria Assi \u00a0 Chapter 40 - Chronic obstruction of the inferior vena cava - Andrew J. Meltzer and Jordan R. Stern \u00a0 Chapter 41 - Venous reconstruction in oncologic surgery - M. Libby Weaver, Michael J. Osgood and Ying Wei Lum \u00a0 Chapter 42 - Superior vena cava syndrome - Jamal Jawad Hoballah \u00a0 Chapter 43 - Management of Chronic Thromboembolic Pulmonary Hypertension\u00a0 - Stuart W. Jamieson","merchants_number":1,"ean":9783319652252,"category_id":103,"size":null,"min_price":189,"low_price_merchant_id":70255345,"ID":5024768,"merchants":["euniverse"],"brand":"undefined","slug":"current-management-of-venous-diseases","url":"\/unterhaltung\/produkt\/current-management-of-venous-diseases\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 299.00
Contemporary Kidney Transplantation
Section 1. History of kidney transplantation Section 2. Recipient Selection 1. Indications and contraindications2. Evaluation and selection3. Special considerations in highly sensitized candidates4. Waitlist maintenanceSection 3. Donor Selection1. Living donora. Evaluationb. Selection2. Deceased donora. History of brain death and donation after cardiac death donors b. Evalu... zur Produkt-Seite
4880054 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZjcvODEvYWEvNTIyODMwMjgwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZjcvODEvYWEvNTIyODMwMjgwMDAwMUFfNjAweDYwMC5qcGc=","post_title":"Contemporary Kidney Transplantation","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319196169&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmedizin-pharmazie%2F443955%2Fcontemporary-kidney-transplantation%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Section 1. History of kidney transplantation Section 2. Recipient Selection 1. Indications and contraindications2. Evaluation and selection3. Special considerations in highly sensitized candidates4. Waitlist maintenanceSection 3. Donor Selection1. Living donora. Evaluationb. Selection2. Deceased donora. History of brain death and donation after cardiac death donors b. Evaluation and managementc. Selectioni. Heart beating deceased donors1. Standard criteria donors2. Extended criteria donorsii. Donation after cardiac deathiii. Specific donor issues and considerations1. HBsAg, HBcAb+, HCV donors2. CDC high risk donors3. Donors on ECMOSection 4. Surgical Technique1. Organ preservation and preparation Surgeona. Historyb. Organ preservation solutionsc. Kidney graft biopsy findingsd. Static storage versus machine perfusion pumpi. Machine perfusion equipment ii. Pump parameterse. Kidney graft back table preparationi. Short renal veinii. Multiple arteries or veinsiii. Other anatomic variants2. Recipient kidney transplantation surgical technique a. The standard technique b. Technical considerations in recipients with extensive atherosclerosis i. Endarterectomyii. Renal artery onto vascular graftsc. Venous sclerosis and alternate locationsd. Urinary tract anomalies (neurogenic bladder)e. Special considerations: Robotic recipient kidney transplantation3. Live donor nephrectomya. History and important trends.b. Open donor nephrectomy. i. Operative Techniqueii. Common complicationsc. Laparoscopic donor nephrectomyi. Operative Techniquesii. Common complicationsd. Robotic laparoscopic donor nephrectomy, SILS, and alternate extractions site laparoscopic donor nephrectomy4. Kidney Transplantation with other organs.a. Special technical concerns---Pancreas kidney transplantationb. Others: liver, heart, small bowelSection 4. Anesthesia ManagementSection 5. Organ Procurement Organization and New Kidney Allocation1. History and rationale for the change. 2. Recent changes and what they will mean.a. Reliance on the Kidney Donor Profile Index (KDPI) Score for allocation over the current definitions such as ageb. Consideration for top 20% adult post-transplant survival candidates Estimated Post Transplant survival (EPTS 20%) for 20% or better KDPI kidneys.c. Sensitization addressed in stratified fashion with special measures for the super sensitized-regional 99%, national 100%.d. Simultaneous local and regional allocation of kidneys with KDPI >85%e. Improved access for Blood type B candidates using A2 and A2B donors.f. Elimination of Payback system.g. Waiting time includes prior time on dialysis.h. Elimination of other OPO specific variances.i. Defining Living Donors by procurement not transplant.3. Allocation policies in EU, UK, and other countriesSection 6. Geographic Variations in Kidney Access- Final Rule Wida (UNOS)Section 7. Vulnerable Populations Section 8. Special Consideration in Living Donor Kidney Transplantation1. Necessary components of a living donor team.a. History b. Team components- surgeons, social workers, independent donor advocate.c. When living donors are taken advantage---stories from the US and elsewhere.2. Living kidney donor paired exchanges a. Historyb. Exchange systems and algorithms behind their operation.c. Benefits and potential pitfalls.i. Loss of the medical outii. Legal implicationsSection 9. Early and Late Course after Kidney Transplantation1. Early complications after kidney transplantationd. Technicali. Vascularii. Urinaryiii. Wound problemsiv. Lymphocele formatione. Medicalv. Rejectionvi. Infectionvii. Cardio-vascular eventsviii. Disease recurrence2. Late complications after kidney transplantationSection 10. Immunology of Kidney TransplantationSection 11. Pathology of Kidney Transplantation Section 12. Radiology of Kidney Transplantation1. Radiology in kidney transplantation2. The role of Interventional radiologySection 13. Transplant Immunosuppression 1. History of immunosuppression: an overviewa. History of immunosuppression specific to drug developmentb. Specific Drugsi. Induction therapy---principals and various agentsii. Maintenance therapy- principals and various agentsiii. Newer or more rarely used agents.2. Special consideration f. Hepatitis Cg. HIVSection 14. Tolerance: The Holy grail of TransplantationSection 15. Infection in Kidney Transplanation.Section 16. The Contemporary Successful Kidney Transplant Program1. The Regulatory Environmenta. UNOSb. CMSc. JCHOd. Insurance2. Quality measure of a contemporary kidney transplant program3. The role of transplant coordinators4. The finance of kidney transplantation5. Kidney transplantation in the third millennium in North America: the strategy for success6. Legal issues of transplant programs in North America in the third millennium (HCV transmission at UPMC, HIV , live donor deaths, etc.)Section 17. Epidemiology of Kidney TransplantationSection 18. Ethics of Transplantation 1. History- transplant as a driver of ethics2. Principles3. Special cases Section 19. Psychosocial and financial Aspects of Transplantation Section 20. Pediatric TransplantationSection 21, Special Topics1. Pregnancy after Kidney Transplantation2. Future Directions:a. The artificial Kidney versus the xenograft that can avoid humoral rejection.b. Prevention-Will the epidemiology of kidney failure change.","merchants_number":1,"ean":9783319196169,"category_id":103,"size":null,"min_price":299,"low_price_merchant_id":70255345,"ID":4880054,"merchants":["euniverse"],"brand":"undefined","slug":"contemporary-kidney-transplantation","url":"\/unterhaltung\/produkt\/contemporary-kidney-transplantation\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 239.00
Essentials of Regional Anesthesia
Table of ContentsPart I General Principles of Regional Anesthesia PracticeChapter 1 General Considerations for Regional Anesthesia Practice Svetla Kurteva, Iyabo Olubunmi Muse and Karina GritsenkoChapter 2 Economic Impact, Cost, and Reimbursement Issues Deepti Agarwal and Maunak V. RanaChapter3 Training and Education of a Physician for Regional Anesthesia Chris M. Farlinger and Jo... zur Produkt-Seite
5513633 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZjMvMTIvNTUvNjc2MTMzODEwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZjMvMTIvNTUvNjc2MTMzODEwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9lc3NlbnRpYWxzLW9mLXJlZ2lvbmFsLWFuZXN0aGVzaWEtMzI1MDQxMDQ0LmpwZw==","post_title":"Essentials of Regional Anesthesia","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319748375&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmedizin-pharmazie%2F465651%2Fessentials-of-regional-anesthesia%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Table of ContentsPart I General Principles of Regional Anesthesia PracticeChapter 1 General Considerations for Regional Anesthesia Practice Svetla Kurteva, Iyabo Olubunmi Muse and Karina GritsenkoChapter 2 Economic Impact, Cost, and Reimbursement Issues Deepti Agarwal and Maunak V. RanaChapter3 Training and Education of a Physician for Regional Anesthesia Chris M. Farlinger and Jonathan C. BeathePart II Basics and Clinical Practice in Regional AnesthesiaChapter 4 The Anatomy of Pain and Its Implications for Regional Anesthesiology Practice Harry J. Gould III and Alan David KayeChapter 5 Local Anesthetics and Adjuvants Francesco Vetri, Jose A. Aguirre, Effrossyni G. Votta-Velis and Alain BorgeatChapter 6 Monitoring and Sedation in Regional Anesthesia James Kim and Jeff GadsdenChapter 7 Anticoagulation and Regional Anesthesia Concerns Alan David Kaye, Thomas Ngo Trang, Elyse M. Cornett, Ken Philip Ehrhardt, Jr., Rinoo ShahChapter 8 Regional Anesthesia in the Community Practice Setting Joseph Marino and Brian E. HarringtonPart III Ultrasound-Assisted Nerve BlocksChapter 9 Ultrasound-Guided Peripheral Nerve Blockade Alan Bielsky and David M. PolanerPart IV Continuous Regional Analgesia and Techniques for Regional AnesthesiaChapter 10 Equipment and Clinical Practice: Aids to Localization of Peripheral Nerves Bryan Tischenkel, Beverly Pearce-Smith, Johnny K. Lee and Karina GritsenkoChapter 11 Neuraxial Blockade: Subarachnoid Anesthesia Maria Teresa Gudin, Ram\u00f3n L\u00f3pez-Vicente, Esperanza Ortigosa, Mar\u00eda Del Mar Caro Cascante, Carmen Garcia Molina, Sonia MartinChapter 12 Neuraxial Blockade: Epidural Anesthesia Sreekumar Kunnumpurath, Suneil Ramessur, Adam Fendius, Nalini Vadivelu, Jasmina PerinpanayagamChapter 13 Peripheral Nerve Blocks for the Lower Extremity Sylvia H. Wilson and Anna UskovaChapter 14 Regional and Topical Anesthesia for Endotracheal Intubation Ryan Philip Ellender, Shilpadevi S. Patil, Lien Tran, Scott M. Kleinpeter, Elyse M. Cornett, Alan David KayeChapter 15 Regional Anesthetic Techniques for the Pediatric Patient Vaughn E. Nossaman and Bobby D. NossamanChapter 16 Head and Neck Regional Anesthesia Desiree Persaud and S\u00e9bastien GarneauChapter 17 Upper Extremity Nerve Blocks De QH Tran, Maria Francisca Elgueta Le-Beuffe and Juan Francisco AsenjoChapter 18 Local Anesthesia of the Masticatory Region Henry A. Gremillion, Christopher J. Spencer, Alex D. Ehrlich, and Janice A. TownsendChapter 19 Regional Anesthetic Techniques for Foot Surgery Rick C. Chen and Peter A. BlumeChapter 20 Selective Regional Anesthesia Options in Surgical Subspecialties Hong Yan, Alan David Kaye and Henry LiuChapter 21 Obstetric Anesthesiology Debbie Chandler, Ray Paschall, Leslie Robichaux, Burton Beakley, Elyse M. Cornett, Alan David KayeChapter 22 Acute Situations: Trauma in Surgical Specialties Sandra Giannone, Daniela Ghisi, Andrea Fanelli, Carl C. RestChapter 23 Preemptive Analgesia, Regional Anesthesia and Prevention of Chronic Postoperative Pain Erik M. Helander, Jonathan P. Eskander, Christina L. Juneau, Matthew B. Novitch, Amit Prabhakar, Amy M. DeKerlegand, Elyse M. Cornett, Alan David KayeChapter 24 Transverse Abdominal Plane, Pectoral and Serratus Plane, and Quadratus Lumborum Blocks Rita Merman, Vladislav Shick and Vikram BhasinPart V Regional Anesthesia and SubspecialtiesChapter 25 Outpatient Surgery Kelly R. MercerChapter 26 Regional Anesthesia in the Critical Care Setting Amir O. Elhassan, Harish Bangalore Siddaiah, Brendon M. Hart, Mark Ryan Jones, Cory A. Roberts, Maura Elise Jones, Alan David KayePart VI Regional Anesthesia for Chronic SituationsChapter 27 Regional Anesthesia for Chronic Pain Neil Malhotra, Vijay Krishnamoorthy, Effrossyni G. Votta-Velis, Alain BorgeatChapter 28 Regional Anesthesia Considerations for Chronic Non-cancer Pain Lauren K. Eng, Lindsey K. Okada and Matthew R. EngChapter 29 Malignant Pain Kenneth D. Candido and Teresa M. KusperChapter 30 Regional Anesthesia and Cardiovascular Disease Veerandra Koyyalamudi, Lien Tran, Camellia D. Asgarian, Molly Kraus, Zacherie Conover, Jeremy Alvrod, Elyse M. Cornett, Alan David KayeChapter 31 Regional Anesthesia in the Patient with Preexisting Neurological Disease Rafael Justiz and Alexander F. BautistaChapter 32 Sympathetic Blockade Miles Day, Rafael Justiz, Audra Day and Maxim S. EckmannPart VII Outcomes Studies in Regional AnesthesiaChapter 33 Outcome Studies and Infection Control in Regional Anesthesia Joshua Ryan Dooley and Stuart Alan Grant Chapter 34 Acute Pain Management Alan David Kaye, Brooke V. Towne, Vibhav B. Reddy, Michael F. Kelley, Jr., Si Zhang, Lien Tran, Elyse M. Cornett, Ralf E. GebhardChapter 35 Regional Anesthesia for Chronic Disease States Siamak Rahman and Parisa PartownavidChapter 36 Intravenous Regional Anesthesia Lindsey Vokach-Brodsky, Vibhav B. Reddy, Kathryn Teixeira, Elyse M. Cornett, Julie Gayle, Patricia B. Sutker, Alan David KayeChapter 37 Pediatric Pain Lori-Ann Oliver, Jodi-Ann Oliver, Hassan Rayaz and J. Lance LicthorPart VIII Future Trends in Regional AnesthesiaChapter 38 Future Trends in Equipment Neda Sadeghi and Jeff GadsdenChapter 39 Future Trends in Regional Anesthesia Techniques Amanda Kumar and Jeff Gadsden","merchants_number":2,"ean":9783319748375,"category_id":103,"size":null,"min_price":239,"low_price_merchant_id":70255345,"ID":5513633,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"essentials-of-regional-anesthesia","url":"\/unterhaltung\/produkt\/essentials-of-regional-anesthesia\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 211.00
Polyamines
Preface...Table of Contents...Contributing Authors...1. Polyamines in the Context of Metabolic NetworksWegi Wuddineh, Rakesh Minocha, and Subhash C. Minocha2. Molecules for Sensing Polyamines and Transducing their Action in PlantsTomonobu Kusano, GHM Sagor, and Thomas Berberich3. Polyamine Metabolism Responses to Biotic and Abiotic StressFernando M. Romero, Santiago J. Maiale, Franco ... zur Produkt-Seite
4852994 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvMWUvZDMvMTYvNjU0OTk4NTYwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvMWUvZDMvMTYvNjU0OTk4NTYwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9wb2x5YW1pbmVzLTI3MzU0ODEzMS5qcGc=","post_title":"Polyamines","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9781493973972&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fbiologie%2F378056%2Fpolyamines-methods-and-protocols%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Preface...Table of Contents...Contributing Authors...1. Polyamines in the Context of Metabolic NetworksWegi Wuddineh, Rakesh Minocha, and Subhash C. Minocha2. Molecules for Sensing Polyamines and Transducing their Action in PlantsTomonobu Kusano, GHM Sagor, and Thomas Berberich3. Polyamine Metabolism Responses to Biotic and Abiotic StressFernando M. Romero, Santiago J. Maiale, Franco R. Rossi, Maria Marina, Oscar A. Ruiz, and Andr\u00e9s G\u00e1rriz4. Thermospermine: An Evolutionary Ancient but Functionally New Compound in PlantsTaku Takahashi5. Determination of Polyamines by Capillary Electrophoresis using Salicylaldehyde-5-Sulfonate as a Derivatizing ReagentTakashi Kaneta6. Detection of Thermospermine and Spermine by HPLC in PlantsTaku Takahashi, Ayaka Takano, and Jun-Ichi Kakehi7. Development of Amine-Oxidase Based Biosensors for Spermine and Spermidine AnalysisCristina Tortolini, Gabriele Favero, and Franco Mazzei8. Identification of Branched-Chain Polyamines in HyperthermophilesRyota Hidese, Wakao Fukuda, Masaru Niitsu, and Shinsuke Fujiwara9. Analysis of Polyamines Conjugated with Hydroxycinnamoyl Acids by High-Performance Liquid Chromatography Coupled to Electrospray Ionization Tandem Mass SpectrometryLaura Torras-Claveria, Jaume Bastida, Francesc Viladomat, and Antonio F. Tiburcio10. Analysis of Glutathione in Biological Samples by HPLC Involving Pre-Column Derivatization with o-PhthalaldehydeYongqing Hou, Xilong Li, Zhaolai Dai, Zhenlong Wu, Fuller W. Bazer, and Guoyao Wu11. Determination of Arginine and Ornithine Decarboxylase Activities in PlantsRub\u00e9n Alc\u00e1zar and Antonio F. Tiburcio12. Determination of S-Adenosylmethionine Decarboxylase Activity in PlantsRub\u00e9n Alc\u00e1zar and Antonio F. Tiburcio13. Determination of Copper Amine Oxidase Activity in Plant TissuesRiccardo Angelini, Alessandra Cona, and Paraskevi Tavladoraki14. Determination of di-\/Polyamine Oxidase Activity in Plants by an In-Gel Spermidine Oxidation AssayPanagiotis N. Moschou15. Pentamine as a Substrate for Measuring Spermine Oxidase ActivityKoichi Takao and Yoshiaki Sugita16. Spectrophotometric Quantification of Reactive Oxygen, Nitrogen and Sulfur Species in Plant SamplesChrystalla Antoniou, Andreas Savvides, Egli Georgiadou, and Vasileios Fotopoulos17. Novel Route for Agmatine Catabolism in Aspergillus niger: 4-Guanidinobutyrase AssayTejaswani Saragadam and Narayan S.Punekar18. Determination of Transglutaminase Activity in PlantsS. Del Duca, P.LR. Bonner, I. Aloisi, D. Serafini-Fracassini, and G. Cai19. Procedures for ADC Immunoblotting and Immunolocalization for Transmission Electron Microscopy during Organogenic Nodule Formation in HopAna Margarida Fortes and Jose M. Segu\u00ed-Simarro20. Analysis of the Intracellular Localization of Transiently Expressed and Fluorescently Labeled Copper-Containing Amine Oxidases, Diamine Oxidase and N-Methylputrescine Oxidase in Tobacco, using an Agrobacterium infiltration ProtocolTsubasa Shoji21. Techniques used for Functional Characterization of Polyamine TransportersClaudio A. Pereira, Melisa Say\u00e9, Chantal Reigada, and Mariana R. Miranda22. Quantitative Trait Loci for Root Growth Response to Cadaverine in ArabidopsisNicole M. Gibbs, Laura Vaughn Rouhana, and Patrick H. Masson23. Methods Related to Polyamine Control of Cation Transport across Plant MembranesIsaac Zepeda-Jazo and Igor Pottosin24. Analysis of DNA Methylation Content and Patterns in PlantsAndreas Finke, Wilfried Rozhon, and Ales Pecinka25. Investigating Ornithine Decarboxylase Post-Transcriptional Regulation via a Pulldown Assay using Biotinylated TranscriptsAnh Mai and Shannon L. Nowotarski26. Analysis of Cotranslational Polyamine Sensing during Decoding of ODC Antiyme mRNAR. Palanimurugan, Daniela G\u00f6dderz, Leo Kurian, and R. J\u00fcrgen Dohmen27. Modulation of Protein Synthesis by Polyamines in Mammalian CellsKeiko Kashiwagi, Yusuke Terui, and Kazuei Igarashi28. Determination of Post-Translational Modifications by 2D-PAGE: Applications to PolyaminesMarta Bitri\u00e1n, Antonio F. Tiburcio, and Rub\u00e9n Alc\u00e1zar29. Generation of EMS-Mutagenized Populations of Arabidopsis thaliana for Polyamine GeneticsKostadin E. Atanasov, Changxin Liu C, Antonio F. Tiburcio, and Rub\u00e9n Alc\u00e1zar30. Transcriptome Analysis of PA Gain and Loss of Function MutantsFrancisco Marco and Pedro Carrasco31. High-Throughput Phenotyping in Plant Stress Response: Methods and Potential Applications to Polyamine FieldD. Marko, N. Briglia, S. Summerer, A. Petrozza, F. Cellini, and R. Iannacone32. Abiotic Stress Phenotyping of Polyamine MutantsT. Berberich, GHM Sagor, and T. Kusano33. Phenotypic and Genotypic Characterization of Mutant Plants in Polyamine Metabolism Genes during Pathogenic InteractionsF.R. Rossi, F.M. Romero, O.A. Ru\u00edz, M. Marina, and A. G\u00e1rriz34. Real-Time In Vivo Monitoring of Reactive Oxygen Species in Guard CellsKy Young Park and Kalliopi A. Roubelakis-Angelakis35. Genome-Wide Association Mapping Analyses Applied to Polyamines Luis Barboza-Barquero, Paul Esker, and Rub\u00e9n Alc\u00e1zar36. Polyamine Metabolism in Climacteric and Non-Climacteric Fruit RipeningAna Margarida Fortes and Patricia Agudelo-Romero37. Application of Polyamines to Maintain Functional Properties in Stored FruitsMar\u00eda Serrano and Daniel Valero38. Acrolein: An Effective Biomarker for Tissue Damage Produced from PolyaminesKazuei Igarashi, Takeshi Uemura, and Keiko Kashiwagi39. Polyamines and CancerElisabetta Damiani and Heather M. Wallace40. Potential Applications of Polyamines in Agriculture and Plant BiotechnologyAntonio F. Tiburcio and Ruben Alc\u00e1zar","merchants_number":2,"ean":9781493973972,"category_id":103,"size":null,"min_price":211,"low_price_merchant_id":70255345,"ID":4852994,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"polyamines-1","url":"\/unterhaltung\/produkt\/polyamines-1\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 178.00
Management of Soft Tissue Sarcoma
Management of Soft Tissue Sarcoma Table of Contents Preface Part I Introduction 1. General Description · Introduction· Incidence and Prevalence· Predisposing and Genetic Factors· References 2. Natural History - Importance of Size, Site, Histopathology· Natural History· Influence of Si... zur Produkt-Seite
4884458 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvMjUvM2MvYTcvNTgxNzY1NTIwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvMjUvM2MvYTcvNTgxNzY1NTIwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9tYW5hZ2VtZW50LW9mLXNvZnQtdGlzc3VlLXNhcmNvbWEtMjcwNTE3OTE2LmpwZw==","post_title":"Management of Soft Tissue Sarcoma","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319419046&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmedizin-pharmazie%2F450370%2Fmanagement-of-soft-tissue-sarcoma%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0Management of Soft Tissue Sarcoma\u00a0\u00a0Table of Contents\u00a0Preface\u00a0\u00a0Part I Introduction\u00a01.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 General Description \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Introduction\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Incidence and Prevalence\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Predisposing and Genetic Factors\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a02.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Natural History - Importance of Size, Site, Histopathology\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Natural History\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Influence of Site\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Staging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Staging of Retroperitoneal Visceral Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Prognostic Factors for Extremity and Superficial Soft Tissue Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Disease-Specific Survival\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Prognostic Factors for Survival Following Local Recurrence of Extremity Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Prognostic Factors: Nomograms\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References \u00a03.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 General Statement as to Efficacy Surgery \/ Chemotherapy \/ Radiation Therapy\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Extent of primary surgery \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Surgical Treatment of Local Recurrence\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnostic Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Surgery for Metastatic Diseaseo\u00a0\u00a0 Pulmonary Metastasiso\u00a0\u00a0 Surgery and the Management of Sarcoma Liver Metastasis\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Radiation Therapyo\u00a0\u00a0 Adjuvant Radiation Therapyo\u00a0\u00a0 Dose of Radiation Therapy o\u00a0\u00a0 Adjuvant Brachytherapyo\u00a0\u00a0 Radiation Therapy in the Presence of Positive Microscopic Marginso\u00a0\u00a0 Definitive Radiation Therapyo\u00a0\u00a0 Radiation to Patients with Neurovascular Involvemento\u00a0\u00a0 Wound Complications of Radiation Therapyo\u00a0\u00a0 Adjuvant and Neoadjuvant Chemotherapy for Soft Tissue Sarcomaso\u00a0\u00a0 Sarcomas More Common in Adultso\u00a0\u00a0 Larger Randomized Studieso\u00a0\u00a0 Selected Meta-analyses of Randomized Trials of Adjuvant Chemotherapyo\u00a0\u00a0 Adjuvant Therapy for GISTo\u00a0\u00a0 Sarcomas More Common in Pediatric Settingo\u00a0\u00a0 Brief comments regarding chemotherapy for metastatic soft tissue sarcomao\u00a0\u00a0 Newer Systemic Agents\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Special Techniques for Primary & Locally Recurrent Diseaseo\u00a0\u00a0 Intra-arterial Chemotherapyo\u00a0\u00a0 Limb Perfusion and Hyperthermia o\u00a0\u00a0 Immunotherapy for Sarcomas\u00a0\u00a0Part II\u00a0\u00a0 Management by Histopathology \u00a04.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Gastrointestinal stromal tumor \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Familial GIST\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Natural History\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis \/ Molecular Pathology\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatmento Adjuvant Imatinib for Primary GISTo Neoadjuvant Therapy for Primary Disease not amenable to Surgeryo Treatment of Recurrence o Imatinib: The First Small Molecule Oral Kinase Inhibitor for Metastatic GIST Failing Imatinib & Sunitinibo Systemic Targeted Therapy for Metastatic GISTo Dose Intensity over Timeo Imatinib Pharmacokinetics\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Second-Line Sunitinib for Imatinib-Resistant Metastatic GISTo Other Tyrosine Kinase Inhibitors for Metastatic GISTo Failing Imatinib and Sunitinib o GRID Trial\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Newer Agents for GIST \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a0 5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Liposarcoma \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Radiation Therapy for Liposarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Systemic Therapy: General Considerations\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adjuvant Therapy\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment of Metastatic Disease\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome Following Metastasis\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a06.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Leiomyosarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis, Molecular Pathology\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Radiation Therapy\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Systemic Therapyo\u00a0\u00a0 Adjuvant Chemotherapy for Leiomyosarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcomes after Primary Therapy\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Patterns of Recurrence\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment of Recurrence\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Metastatic Disease\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a07.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Undifferentiated Pleomorphic Sarcoma (UPS) (Malignant Fibrous Histiocytoma:\u00a0 MFH) Myxofibrosarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis, Molecular Pathology\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Natural History\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Radiation Therapy \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Metastatic Disease\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adjuvant Chemotherapy\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a08.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Synovial Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis, Molecular Pathology\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Radiation Therapy\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Chemotherapy\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment of Recurrenceo\u00a0\u00a0 Local Recurrenceo\u00a0\u00a0 Systemic Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Malignant Peripheral Nerve Sheath Tumor (MPNST) \/ Triton Tumor\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Presentation\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis, Pathology\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neurofibromatosis Type 1 and Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Radiation Therapy \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Chemotherapy for MPNST\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a0\u00a010.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Desmoid Tumor \/ Deep-Seated Fibromatosis (Desmoid-Type Fibromatosis)\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical Presentation\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis, Molecular Pathology\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Natural History\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment of Recurrence\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment by Observation\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Radiation Therapy \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Patterns of Failure\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a011.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Solitary Fibrous Tumor \/ Hemangiopericytoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Doege-Potter Syndrome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary Therapy\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Systemic Therapy for Metastatic Disease\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a012.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fibrosarcoma and its Variants\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dermatofibrosarcoma Protuberans\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Low-Grade Fibromyxoid Sarcoma (of Evans Tumor)\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sclerosing Epithelioid Fibrosarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Inflammatory Myofibroblastic Tumor\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infantile Fibrosarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Myxoinflammatory Fibroblastic Sarcoma \/ Inflammatory Myxohyaline Tumor of Distal Extremities\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adult-Type Fibrosarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a013.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Vascular Sarcomas\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Epithelioid Hemangioendothelioma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Angiosarcoma \/ Lymphangiosarcoma \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Kaposi Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a014.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Epithelioid Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a015.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sarcomas More Common in Children Soft Tissue Sarcomas More Commonly Observed in Pediatric Patients Ewing Sarcoma Family of Tumors (EFT) Demographics Primary Therapy Adjuvant Chemotherapy High-Dose Systemic Therapy for Metastatic Disease Standard Cytotoxic Chemotherapy After Disease Relapse Investigational Approaches Ewing Sarcoma-Like Tumors Rhabdomyosarcoma Demographics Molecular Biology Risk Stratification Staging Imaging Primary Therapy Chemotherapy for Metastatic Disease Embryonal Sarcoma References \u00a016.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Radiation-Induced Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a017.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Alveolar Soft Part Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis, Molecular Pathology\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment of Metastatic Disease\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a018.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clear Cell Sarcoma \/ Melanoma of Soft Parts\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis, Molecular Pathology\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a019.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Desmoplastic Small Round Cell Tumor\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a0 20.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Extraskeletal Myxoid Chondrosarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mesenchymal Chondrosarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a021.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Other Uterine Sarcomas\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Low Grade Endometrial Stromal Sarcomao\u00a0\u00a0 Diagnosiso\u00a0\u00a0 Treatment\u00a0 o\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 High Grade Endometrial Stromal Sarcomao\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Undifferentiated Uterine Sarcoma (UUS)\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Uterine Carcinosarcomas and Other Malignant Mixed M\u00fcllerian Tumors\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PEComaso\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a022.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Extraskeletal Osteogenic Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Imaging\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a023.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sustentacular Tumors of Lymph Tissue\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Follicular Dendritic Cell Tumor (Dendritic Reticulum Cell Tumor [FDCT]) and Interdigitating Reticulum Cell Tumor (IDRCT)\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 True Histiocytic Sarcoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Langerhans Cell Tumors\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a024.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Uncommon \/ Unique Sites\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Heart and Great Vessels\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary Sarcomas of the Breasto\u00a0\u00a0 Phylloides Tumoro\u00a0\u00a0 Diagnosiso\u00a0\u00a0 Outcome\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Head and Necko\u00a0\u00a0 Treatment\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary Sarcomas of the Mediastinum\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Liver\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0Part III\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Benign and Less Aggressive Lesions \u00a025.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mostly Benign \/ Rarely Metastasizing\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ossifying Fibromyxoid Tumor\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Perivascular Epithelial Cell Tumor (PEComa) & Related Entities,\u00a0 Lymphangioleiomyomatosis, Angiomyolipoma, and Sugar Cell Tumor\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Therapy\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Giant Cell Tumor of Tendon Sheath \/ Pigmented Villonodular Synovitis\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Myoepithelioma of Soft Tissue\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Glomus tumor \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 26.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Benign Tumors\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Lipoma\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Lipomatosis \u00a0 \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Lipoblastoma \/ Lipoblastomatosis \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Angiolipoma \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Angiomyolipoma \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Angiomyelolipoma \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hibernoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Elastofibroma \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Granular Cell Tumor\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hemangioma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Leiomyoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Schwannoma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neurofibroma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Myxoma \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Angiomyxoma \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Angiofibroma\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a027.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Reactive Lesions\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Myositis Ossificans\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nodular Fasciitis\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sarcoma Masquerade\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 References\u00a0\u00a0\u00a0Suggested Keywords\u00a0Index","merchants_number":2,"ean":9783319419046,"category_id":103,"size":null,"min_price":178,"low_price_merchant_id":70255345,"ID":4884458,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"management-of-soft-tissue-sarcoma","url":"\/unterhaltung\/produkt\/management-of-soft-tissue-sarcoma\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 59.15
Psychodynamic Perspectives on Aging and Illness
Endorsements:"The Second Edition of ,Psychodynamic Perspectives on Aging and Illness ,is a timely and superb revision which offers health-care professionals working at the mind/body interface a paradigm shift. , For far too long, the wisdom of psychoanalysis as a tool to understand the suffering inherent in aging and illness has been devalued and neglected. With this updat... zur Produkt-Seite
4882544 {"price-changing":null,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9jNC1zdGF0aWMuZG9kYXguY29tL3YyLzE4MC0xODAtMTIzMTM2MTg1X2RKTGIyMmUtcG5n!aHR0cHM6Ly9jNC1zdGF0aWMuZG9kYXguY29tL3YyLzE4MC0xODAtMTIzMTM2MTg1X2RKTGIyMmUtcG5n","post_title":"Psychodynamic Perspectives on Aging and Illness","deeplink":"https:\/\/www.awin1.com\/pclick.php?p=24494053129&a=401125&m=11816&pref1=9783319488493","labels":[],"brand_id":1,"post_content":"Endorsements:\"The Second Edition of ,Psychodynamic Perspectives on Aging and Illness ,is a timely and superb revision which offers health-care professionals working at the mind\/body interface a paradigm shift. , For far too long, the wisdom of psychoanalysis as a tool to understand the suffering inherent in aging and illness has been devalued and neglected. With this update, Dr. Greenberg incontrovertibly corrects this lapse. Her integration of current scientific research, alongside a user-friendly discussion of the theory and practice of psychodynamic psychotherapy, is an important contribution to the psychology of medicine. , Several topics are elaborated, the constructs of hysteria and somatization, the biology of stress, the impact of attachment history on coping with sickness as well as the experiences of trauma and grief. As with the first edition, the idea that the patient\u2019s experience of illness cannot be understood without including the subjectivity of the practitioner who provides care is considered and done so with more awareness of this complexity. , Each chapter now contains a section on \u201cSuggested Techniques\u201d that succinctly presents a guideline for applying the ideas set forth. Other no ,table aspects of the book are its reflections on the culture of medicine and the insights about the influences of contemporary Western life on the manifestation and adjustment to illness. , This edition is, above all, essential for those practitioners dedicated to providing collaborative and interdisciplinary health-care which is both biologically and psychologically informed. , As with the First Edition, it will continue to be required reading.\" Marilyn S. Jacobs, Ph.D., ABPP, David Geffen School of Medicine at UCLA\"A wonderful, well-researched, and important book that proves to be as much about humanity and resilience as it is about human psychology.\" Lee Daniel Kravetz Author of Supersurvivors: ,The ,surprising Link Between ,Suffering & Success\"Tamara McClintock Greenberg is one of the leading health psychologists of our time. , ,In this second edition of her classic text, she corrects the much overlooked interface between the psychodynamics of aging, illness, and the doctor-patient relationship offering insights that no other practitioner or theorist has accomplished to date. ,Combining her training and expertise in psychology and behavioural medicine, she facilely navigates the turbid waters of how medical illness and aging is informed by unconscious dynamics, childhood familial relations, somatisation, coping and recovery, and the convergence of mind and body. , ,Healthcare practitioners of all types who work therapeutically with chronically ill and older adults will find this to be a perspicacious and indispensible approach to clinical praxis.\" Jon Mills, PsyD, PhD, C.Psych., ABPP, Professor of Psychology & Psychoanalysis, Adler Graduate Professional School, Toronto \u201cIn the second edition of ,Psychodynamic Perspectives on Aging and Illness ,Dr Tamara Greenberg makes a remarkable contribution to those who treat patients with medical illnesses as they age. Her psychodynamically informed approach to patients in later life couldn\u2019t come at a better time as our population becomes older. Challenging the field's dogma that older patients are too set-in-their-ways to make personality changes, Dr Greenberg demonstrates in this book how wrong that notion was. We are all a work in-progress until the very end. This is a must-read practical book for therapists, nurses, families, physicians, family and estate lawyers, and health care navigators.\u201d Louann Brizendine, M.D., Professor and Author of \"The Female Brain\" and \"The Male Brain\" ,, Lynne and Marc Benioff Endowed Professor of Clinical Psychiatry, Founder\/ Women's Mood and Hormone Clinic, UCSF University of California, San FranciscoThis timely update of the bedrock text reflects what we now know\u2014and are still finding out\u2014about the benefits of psychodynamic psychotherapy for older adults facing chronic conditions. Expanding on the original, the author balances the physical and experiential factors affecting patients\u2019 physical illnesses and related emotional distress while situating core psychodynamic constructs in the context of illness and aging. Special attention is paid to technique, giving therapists practical guidance on dealing with transference and countertransference issues, working with patients in cognitive decline, and navigating complexities of age, class, and culture. The book also reviews the current evidence on how and why psychodynamic therapy helps medical patients with coping, adapting, and healing. , Included in the coverage: , Technology, idealization, and unconscious dynamics in the culture of medicine.Narcissistic aspects of aging and illness. Grey areas: when illness may be particularly impacted by psychological variables. Cognitive changes and implications for the therapeutic encounter.The influence of psychological factors and relationships on medical illness.Hope and grief: the introduction of an emotional language. The Second Edition of Psychodynamic Perspectives on Aging and Illness skillfully follows its predecessor as a powerful, plain-spoken mentor to therapists working in hospitals, long-term care facilities, and outpatient practice.","merchants_number":1,"ean":9783319488493,"category_id":103,"size":null,"min_price":59.14999999999999857891452847979962825775146484375,"low_price_merchant_id":1087639,"ID":4882544,"merchants":["dodax"],"brand":"undefined","slug":"psychodynamic-perspectives-on-aging-and-illness-2","url":"\/unterhaltung\/produkt\/psychodynamic-perspectives-on-aging-and-illness-2\/","low_price_merchant_name":null}
Produkt merken zur Merkliste CHF 211.00
The Median Nerve
Introduction.- List of abbreviations.- Synoptic table.- Sensory conduction studies index (according to practical criteria).- Part 1 Sensory conduction studies.- S1 Orthodromic technique at the wrist and at the elbow, stimulation of digit II.- S2 Orthodromic technique at the wrist and at the elbow, stimulation of digit II and of the wrist.- S3 Orthodromic technique at the wrist, at the... zur Produkt-Seite
4859939 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZjYvYTAvNjkvNDc0MTQyNzAwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZjYvYTAvNjkvNDc0MTQyNzAwMDAwMUFfNjAweDYwMC5qcGc=","post_title":"The Median Nerve","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319104751&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmedizin-pharmazie%2F441921%2Fthe-median-nerve-sensory-conduction-studies%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Introduction.- List of abbreviations.- Synoptic table.- Sensory conduction studies index (according to practical criteria).- Part 1 Sensory conduction studies.- S1 Orthodromic technique at the wrist and at the elbow, stimulation of digit II.- S2 Orthodromic technique at the wrist and at the elbow, stimulation of digit II and of the wrist.- S3 Orthodromic technique at the wrist, at the elbow and at the axilla, stimulation of digit II and of the wrist.- S4 Orthodromic technique at the wrist and at the elbow, stimulation of digit II and III.- S5 Antidromic technique of digit II and III, stimulation of the wrist and of the elbow.- S6 Orthodromic technique on the palm and at the wrist, stimulation of digit III.- S7 Orthodromic technique at the wrist, stimulation of digit II and V.- S8 Orthodromic technique on the palm and at the wrist, stimulation of digit I and III.- S9 Orthodromic technique of digit III and at the wrist, stimulation of digit III.- S10 Orthodromic technique at the wrist and at the elbow, stimulation of digit I and III.- S11 Orthodromic technique at the wrist, stimulation on the palm.- S12 Antidromic technique of digit II, stimulation of the elbow and of the wrist.- S13 Antidromic technique of digit II and V, stimulation of the wrist.- S14 Antidromic technique of digit II and V, stimulation of the wrist.- S15 Antidromic technique of digit II, stimulation of the elbow, wrist and on the palm.- S16 Antidromic technique of digit II, stimulation of the elbow, wrist and on the palm.- S17 Antidromic technique of digit II, stimulation of the wrist and on the palm.- S18 Antidromic technique of digit II and V, stimulation on the palm and of the wrist.- S19 Antidromic technique of digit I, stimulation of the wrist.- S20 Antidromic technique of digit III, stimulation of the wrist and on the palm.- S21 Antidromic technique of digit IV, stimulation of the wrist.- S22 Orthodromic technique at the wrist, stimulation of digit I.- S23 Antidromic technique of digit III, stimulation of the wrist and on the palm.- S24 Orthodromic technique at the wrist, stimulation of digit II, V and on the palm.- S25 Orthodromic technique at the wrist, stimulation of digit II, V and on the palm.- S26 Orthodromic technique at the wrist, stimulation of digit II, III and on the palm.- S27 Antidromic technique of digit I, II, III and IV, stimulation of the wrist and on the palm.- S28 Antidromic technique of the palmar cutaneous branch, stimulation at the distal forearm.- S29 Orthodromic technique at the wrist, stimulation of digit I.- S30 Antidromic technique of digit I, stimulation of the wrist.- S31 Orthodromic technique at the arm and at the axilla, stimulation on the palm and of the wrist.- S32 Orthodromic technique at the wrist, stimulation of digit II, III, V and on the palm.- S33 Orthodromic technique at the wrist, stimulation of digit IV.- S34 Antidromic technique of the wrist, stimulation at the forearm.- S35 Orthodromic technique at the wrist, stimulation of digit I, II, III and IV.- S36 Orthodromic technique at the wrist and at the distal forearm, stimulation of digit I and of the palmar cutaneous branch.- S37- Orthodromic technique at the wrist, stimulation of digit IV.- S38 Antidromic technique to the digit II, stimulation of the wrist and on the palm.- S39 Antidromic technique of digit I, II, III and IV, stimulation of the wrist.- S40 Orthodromic technique at the wrist, stimulation of digit III and on the palm.- S41 Orthodromic technique at the wrist, stimulation of digit I, II, III, IV and V.- S42 Antidromic technique of digit II and I, stimulation of the wrist.- S43 Orthodromic technique at the wrist, stimulation on the palm.- S44 Orthodromic technique at the wrist, stimulation on the palm. Antidromic techniques of digit IV and I, stimulation of the wrist.- S45 Antidromic technique of digit II and V, stimulation of the wrist.- S46 Orthodromic technique at the wrist, stimulation on the palm.- S47 Orthodromic technique at the wrist, stimulation on the palm.- S48 Orthodromic technique at the elbow, stimulation on the palm and at the wrist. Antidromic technique of digit II, stimulation on the palm, at the wrist and at the elbow.- S49 Orthodromic technique at the distal forearm, stimulation of the palmar cutaneous branch.- S50 Orthodromic technique on the palm and at the wrist, stimulation of digit II and III. Antidromic technique of digit II and III, stimulation on the palm and at the wrist.- S51 Antidromic technique of digit III, stimulation of the wrist.- S52 Antidromic technique of the palmar cutaneous branch, stimulation of the wrist.- S53 Antidromic technique on the palm, stimulation of the wrist.- S54 Orthodromic technique at the elbow, stimulation of the wrist. Orthodromic technique at the wrist and at the elbow, stimulation on the palm.- S55 Antidromic technique of digit II and III, stimulation on the palm, of the wrist and of the elbow.- Part 2.- Glossary.- Subject Index.","merchants_number":1,"ean":9783319104751,"category_id":103,"size":null,"min_price":211,"low_price_merchant_id":70255345,"ID":4859939,"merchants":["euniverse"],"brand":"undefined","slug":"the-median-nerve-1","url":"\/unterhaltung\/produkt\/the-median-nerve-1\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 38.90
You Should Test That
Foreword xxiiiIntroduction xxvChapter 1 Why You Should Test That 1Your Website Is Crucial to Your Business 2Your Website Is Underperforming 4All Websites Can Be Improved 4The Halo Effect of Underperformance 5Web Design for Results (Rather than Aesthetics) 9Why "Best Practices" Aren't Best 10Is There a HiPPO in the Room? 11The Risks and Costs of Website Redesign 12Your New Website Desi... zur Produkt-Seite
4182044 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvMzYvOGUvNTcvNDA1NzEzNzQwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvMzYvOGUvNTcvNDA1NzEzNzQwMDAwMUFfNjAweDYwMC5qcGc=","post_title":"You Should Test That","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9781118301302&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Finformatik-edv%2F337287%2Fyou-should-test-that-conversion-optimization-for-more-leads-sales-and-profit-or-the-art-and-scienc%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Foreword xxiiiIntroduction xxvChapter 1 Why You Should Test That 1Your Website Is Crucial to Your Business 2Your Website Is Underperforming 4All Websites Can Be Improved 4The Halo Effect of Underperformance 5Web Design for Results (Rather than Aesthetics) 9Why \"Best Practices\" Aren't Best 10Is There a HiPPO in the Room? 11The Risks and Costs of Website Redesign 12Your New Website Design Could Hurt Your Results 13Your Improvements May Be Overshadowed by Mistakes 13Use Evolutionary Site Redesign 15Conversion-Rate Optimization Increases Revenue without Increasing Advertising Spend 15Comparing Conversion-Rate Optimization with Paid-Search Optimization 15Conversion-Rate Optimization and Your Business 17Conversion-Rate Optimization Results by Industry 17Calculate the Benefit of Conversion-Rate Optimization 18CRO Works alongside SEO 20SEO and CRO Can Play Well Together 20How to Do CRO without Hurting Your SEO 21You Should Test That! 22Chapter 2 What is Conversion Optimization? 23Conversion Optimization Requires Controlled Testing 23The Scientific Method of Controlled Testing 24Selecting a Sample (Not a Free One, a Statistical One) 25Using a Tool Designed for Controlled Testing 26\"Best Practices\" Are Not Conversion Optimization 27The Before & After Method Is Not Conversion Optimization 29External Factors Mess with Your Data 30Usability Testing Is Not Conversion Optimization 33Surveys Are Not Conversion Optimization 37Click Heatmap Tracking Is Not Conversion Optimization 38What Is Conversion Optimization? 39Who Are Your Target Audiences? 39Target Markets and Personas 40Setting Goals 41Define Your Goals 42The Goals Waterfall 42Prioritize Your Goals 42Should You Optimize for Micro-Conversions? 46Web Analytics Goals vs. Conversion-Optimization Goals 48The Continuous Improvement Cycle 54Continuous Improvement Is Key to Success 55Progress from Macro to Micro 58Chapter 3 Prioritize Testing Opportunities 61Use Data to Prioritize Tests 62Your Web Analytics Data 62Your Home Page Isn't Your Front Door 62View Data at the Page-Template Level 63The PIE Prioritization Framework 66Prioritize Pages with High Potential for Improvement 67Top Exit Pages 67Analyze Your Conversion Funnel 70Gather Qualitative Data 72Prioritize Important Pages 82Pages with High Traffic Volume Are More Important 83Pages with Expensive Visits Are More Important 85Prioritize Easy Test Pages 89Consider Technical Implementation 89Consider Organizational Barriers 94Prioritize with a Weighting Table 94Reprioritize Regularly 95Chapter 4 Create Hypotheses with the LIFT Model 97Methodology Is More Valuable than Tips 98The Gorilla in Our Brains 100The LIFT Model 102The Value Proposition 103Relevance 104Clarity 104Anxiety 105Distraction 106Urgency 107Problems Are Opportunities! 107Fill the Marble Jar 107Create Valid Hypotheses 109The Hypothesis Structure 110Good to Great Hypotheses 111Tips to Get Your Testing Started 112Chapter 5 Optimize Your Value Proposition 113The Value-Proposition Equation 114Your Visitor's Perception Filters 115Tangible Features 118Product or Service Features 118Incentives and Offers 119Intangible Benefits 123Credibility 123Social Proof 128Personal Benefits vs. Business Benefits 136Costs 137The Price 137Delivery Cost 141The Incredible Power of Free 141Associated Costs 143What Is Your Value Proposition? 144Test Your Value Proposition 145Chapter 6 Optimize for Relevance 147Marketing Funnel Relevance 148Source Relevance 150Relevance to Ad Messages 151Relevance to Search Keywords 152Relevance to Emails 158Three Ways to Create Landing-Page Source Relevance 159Target Audience Relevance 160Customer Segmentation 160Call-to-Action Relevance 162Tone Relevance 163Navigation Relevance 167Competitive Relevance 174Chapter 7 Optimize for Clarity 177Information Hierarchy Clarity 178Website-Level Information Hierarchy 178Page-Level Information Hierarchy 181Design Clarity 182Eyeflow Clarity 182Image Clarity 186Color Clarity 191Call-to-Action Clarity 193Copywriting Clarity 195Chapter 8 Optimize for Anxiety 207Privacy Anxiety 208Usability Anxiety 215Form Usability 215Website Errors 217Site Speed 218Effort Anxiety 219Fulfillment Anxiety 223Security 224Fine Print 224Brand Reputation 225Delivery Promise 225Guarantees, Returns, and Unsubscription 226Turn Anxiety in Your Favor 228Chapter 9 Optimize for Distraction 231Two Distraction Points 232First-Impression Distraction 233Look through Your Prospects' Eyes 233Too Much Content 235Daunting Text 237Complex Graphics 238Large Headers 238Redundancy 240Message Distraction 244Too Many Messages 245Irrelevant Content 245Too Many Options 247Navigation Bars 248Image Distraction 248Chapter 10 Optimize for Urgency 255Internal Urgency 256Seasonality's Effect on Urgency 256Create Internal Urgency 262External Urgency 266The Offer's Effect on Urgency 267Create Offer Urgency 268Respond with Urgency 271Chapter 11 Test Your Hypotheses 273Set Test Goals 274Types of Goals 274Use Clickthroughs with Caution 276Goal Triggers 277The One-Goal Goal 279Multi-Goal Tracking 280Choose the Test Area 281Templated Pages 282Individual Static Test Pages 283Individual Pages with Dynamic Content 283Site-Wide Section Tests 283Choose the Test Type 288Consider Traffic Volume 288Multivariate Testing 288A\/B\/n Testing 290My Recommendation: Emphasize A\/B\/n Testing 291Alternative Path Tests 293Isolate for Insights 293How to Get Good Great Results 295Test Boldly 295Test Fewer Variations 296Avoid Committee Testing 296Win with Confidence 296Maintain Your Control 297Use Testing Expertise 297Chapter 12 Analyze Your Test Results 299Reading the Tea Leaves 300Monitoring Your Tests 301Wait for Statistical Significance 301Remove Under-Performers 302Don't Give Up Too Early 302Evaluating Results 303How Accurate Are Your Results? 303Multiple Goals 306Revenue Results 306Compare Isolations 310What to Test Next? 311Re-Prioritize Your Priorities 311Beat the Dreaded Inconclusive Test 311Chapter 13 Strategic Marketing Optimization 313Aim for Marketing Insights 314The Optimization Manifesto 314Be a Marketing Optimization Champion 315Index 319","merchants_number":1,"ean":9781118301302,"category_id":103,"size":null,"min_price":38.89999999999999857891452847979962825775146484375,"low_price_merchant_id":70255345,"ID":4182044,"merchants":["euniverse"],"brand":"undefined","slug":"you-should-test-that","url":"\/unterhaltung\/produkt\/you-should-test-that\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 132.50
A Consumer's Guide to Archaeological Science
Part I Basic Science.-Chapter 1 Elements, Atoms and Molecules.- Matter and the Atom.-The Periodic Table of Elements.-Chemical Bonding.-Chemical Equations.-Cellular Energy.-Electrical Conductivity.-Chapter 2 Electromagnetic Radiation.-Wavelength, Frequency and Energy.-The Electromagnetic Spectrum.-Energy Absorption and Emission by Atoms and Molecules.-Chapter 3 Radioactive Isoto... zur Produkt-Seite
5050985 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvYWIvMzYvMTgvMjQwMTM4MDYwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvYWIvMzYvMTgvMjQwMTM4MDYwMDAwMUFfNjAweDYwMC5qcGc=","post_title":"A Consumer's Guide to Archaeological Science","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9781441957030&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fgeisteswissenschaften-kunst-musik%2Fgeschichte%2F319812%2Fa-consumer-s-guide-to-archaeological-science-analytical-techniques%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Part I Basic Science.-Chapter 1 Elements, Atoms and Molecules.- Matter and the Atom.-The Periodic Table of Elements.-Chemical Bonding.-Chemical Equations.-Cellular Energy.-Electrical Conductivity.-Chapter 2 Electromagnetic Radiation.-Wavelength, Frequency and Energy.-The Electromagnetic Spectrum.-Energy Absorption and Emission by Atoms and Molecules.-Chapter 3 Radioactive Isotopes and Their Decay.-Emissions.-Radioactive Decay.-The Uranium Decay Series.-Nuclear Reactions.-Chapter 4 Stable Isotopes.-Carbon.-Nitrogen.-Strontium.-Lead.-Oxygen.-Hydrogen.-Chapter 5 Organic Compounds.- Important Organic Compound Families.-Lipids.-Amino Acids and Proteins.-Carbohydrates.-Deoxyribonucleic Acid.-Chapter 6 Other Useful Concepts.-Acids and Bases.-Stereochemistry and the Polarimeter.-Chemical Reactions.- Part II Applications.-Chapter 7 Compositional Analysis.-Chapter 8 Radiocarbon dating.-Carbon-14.- Using Radioactive Carbon to Date Organic Material.-Counting beta Emissions.-Accelerator Mass Spectrometry Dating.-Conventional Radiocarbon Ages.-Carbon Exchange Reservoir.-Differences in Circulation Time in the Carbon Cycle.-Secular Variation.-Converting Radiocarbon Ages Into Calendar Dates.-Sampling Considerations.-Sample Pretreatment.-Current Issues in Radiocarbon Dating.-Less Destructive Sampling Techniques.-Judging the Quality of Radiocarbon Dates.-Conclusions.-Chapter 9 Other Radioactive Decay Based Dating Techniques.-Uranium Series Dating.-Using Uranium as a Clock.-Measuring Radioactivity.-Sample Selection.-Biogenetic materials and Uranium Uptake.-Sample Preparation.- Sample Contamination.-Potassium-Argon and Argon-Argon Dating.- The Production of Radiogenic Argon.- Procedures for Obtaining a K-Ar Date.- Procedures for Obtaining an Ar-Ar Date.-Fission Track Dating.-Sample Requirements.-Procedure.-Age Calculation.-Age Range and Potential Errors.-Chapter 10 Trapped Charge Dating.-Theoretical Considerations.-Measuring the Population of Trapped Charges.-Thermoluminescence Dating.-Optically Stimulated Luminescence Dating.-Electron Spin Resonance Dating.-Determining the Paleodose Dose.-Additive (Dose) Method.-Regeneration Technique.-Partial Bleach(ing) Technique.-Regeneration Method.-Single Aliquot Regeneration (SAR).-The Plateau Test.-Sources of the Annual Dose.-External Contribution.-Internal Contribution.-Uranium Uptake.-Dating Limitations and Sources of Error.-Potential Benefits of Trapped Charge Dating.-Chapter 11 Other Dating Techniques.-Amino Acid Racemization.-Archaeomagnetism.-Obsidian Hydration.-Cation Ratio.-Chapter 12 Provenance Studies.-Chapter 13 Stable Isotope Analysis.-Stable Carbon Isotope Ratio Analysis.-Sample Selection.-Factors Affecting d13C values.-Summary.-Stable Nitrogen Isotope ratio Analysis.-Sample Selection.-Factors affecting d15N Values.-Using Linear Mixing Models to Reconstruct Paleodiets.-Stable Strontium Isotope Analyses.-Strontium to Calcium Ratios.-Sample Selection and Processing.-Using Strontium Isotope Ratios to Trace Migrations.-Stable Lead Isotope Analysis.-The Occurrence of Lead in Metal.-The Study of Lead in Body Tissue.- Oxygen Isotope Analysis.-Oxygen Isotope Fractionation.-Sample Selection and Processing.-Chapter 14 Lipid Residues.-Chapter 15 Blood and Protein Analysis.-Protein and Blood.-Screening Techniques.-Microscopy.-Colorimetric Methods of Protein Determination.-Urinalysis Test Strips.-Techniques Used for Species Specific Identifications.-Hemoglobin (Hb) Crystallization.-Using the Immune Response to Identify Proteins.-Detecting the Antibody-Antigen Complex.-The Immune Response in Archaeological Residues.-Survival of Proteins.-Survival of Blood Proteins.-The Question of Reliability.-Cross Reactions and Antibody Selection.-Blind Test Results.-Blood Residues Vs. Faunal Assemblages.-Recent Studies.-Conclusions.-Chapter 16 Ancient DNA and the Polymerase Chain Reaction.-The Preservation of Ancient DNA.-The Polymerase Chain Reaction.-Analysis after Amplification.-Sample Selection.-Extraction.-Selection of DNA Primers.-Challenges Associated with Analyzing Ancient DNA.-Amplification of Poorly Preserved DNA.-Strategies for Managing PCR Inhibitors.-Avoiding Contamination.-Conclusions.-Special Topic: DNA Cloning.-Insertion of Foreign DNA into Cloning Vectors.-Plasmids.-Bacteriophages.- Special Topic: DNA Sequencing.-Part IIi Materials.-Chapter 17 Pottery and other Ceramic Artifacts.-Chapter 18 Flaked and Groundstone Tools.-Chapter 19 Bone and Teeth.-Chapter 20 Cultural Rock-Chapter 21 Food Residues.-Chapter 22 Blood Residues.-Chapter 23 Other Organic Residues.-Chapter 24 Organic Remains.-Chapter 25 Paint, Pigments and Ink.-Chapter 26 Metal.-Chapter 27 Glass.-Chapter 28 Matrix and Environmental Deposits.-Chapter 29 Other Materials.- Part Iv.- Instrumentation.-Chapter 30 Sample Selection and Processing.-Sample Solutions.-Analysis of Solid Samples.-Special Topic: LASER: Light Amplification by Stimulated Emission of Radiation.-Chapter 31 Mass Spectrometry.-Ionization.- Techniques for Molecular Mass Analysis.-Electron Impact.-Soft Ionization Techniques.-Techniques used with LC-MS.-Techniques of Atomic Mass Analysis.-Secondary Ion Mass Spectrometry.-Laser Ablation Mass Spectrometry.-Thermal Ionization Mass Spectrometry.-Mass Analysis.-Magnetic Sector.-Quadrupole.-Ion Trap.-Time of Flight.- Ion Detection.-Faraday Cup.-Photomultiplier.-Electron Multiplier.-Chapter 32 Instrumental Neutron Activation Analysis.-Radionuclide Formation and Emissions.-Sample Preparation and Analysis Identification and Quantification of Elements.-Chapter 33 Separation Techniques.-Chromatography.-Thin Layer Chromatography.-High Pressure (or Performance) LiquidChromatography.-Liquid Chromatography with Mass Spectrometry.-Gas Chromatography.-Component Separation.-Detectors.-Electrophoresis.-Electrophoresis of Proteins.-Isoelectric Focusing Point.-Separation by Weight.-Chapter 34 Atomic Absorption and Emission Spectroscopy.-Atomic Absorption Spectroscopy.-Sample Atomization.- Light Sources.-Detection.-Advantages and Disadvantages.-Optical Emission Spectroscopy.-Inductively Coupled Plasma-Atomic Emission Spectroscopy.-ICP with Mass Spectrometry.-Chapter 35 Optical Spectroscopy.-Ultraviolet and Visible Spectroscopy.-Instrumentation.-Infrared Spectroscopy.-Sample Preparation and Instrumentation.-Fourier Transform IR Spectrometers.-Photoacoustic Spectroscopy.-Raman Spectroscopy.-Attenuated Total Reflectance Spectroscopy.-Chapter 36 Resonance Spectroscopy.-Nuclear Magnetic Resonance Spectroscopy.-Instrumentation and Sample Analysis.-Proton NMR Spectra.-Chemical Shift.-Spin-Spin (or Signal) Splitting.-Carbon-13 NMR.-Fourier Transformation.-Electron Spin Resonance Spectroscopy.-Instrumentation.-Analysis of the ESR Signal.-Chapter 37 X-ray and Particle Induced Emission Techniques.-X-rays and X-radiography.- X-ray Diffraction.-Diffraction of X-rays by Crystalline.- Materials.-Sample Analysis.-X-ray Fluorescence Spectrometry.-Sample Preparation.-Instrumentation.-Proton\/Particle Induced X-ray Emission (PIXE) and Gamma-ray Emission (PIGE).-Sample Preparation.-Surface Characterization Techniques.-Surface Characterization.-Scanning Electron Microscopy with ED XRF.-Sample Requirements.-Electron Microprobe.-Sample Requirements.-Chapter 38 Elemental Analysis.-Instrumentation.-Data Analysis.-Chapter 39 M\u00f6ssbauer Spectroscopy.-Instrumentation.-Sample Requirements.- Data Interpretation.-Glossary.-References.-","merchants_number":1,"ean":9781441957030,"category_id":103,"size":null,"min_price":132.5,"low_price_merchant_id":70255345,"ID":5050985,"merchants":["euniverse"],"brand":"undefined","slug":"a-consumers-guide-to-archaeological-science","url":"\/unterhaltung\/produkt\/a-consumers-guide-to-archaeological-science\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 111.00
A Chronicle of Permutation Statistical Methods
Preface.- 1.Introduction.- 2.1920-1939.- 2.1.Overview of Chapter 2.- 2.2.Neyman-Fisher-Geary and the Beginning.- 2.3.Fisher and the Variance-ratio Statistic.- 2.4.Eden-Yates and Non-normal Data.- 2.5.Fisher and 2 by 2 Contingency Tables.- 2.6 Yates and the Chi-squared Test for Small Samples.- 2.7.Irwin and Fourfold Contingency Tables.- 2.8.The Rothamsted Manorial Estate.- 2.9.Fisher a... zur Produkt-Seite
4882136 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvOTEvOWQvNGYvNTk3OTQ5NDYwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvOTEvOWQvNGYvNTk3OTQ5NDYwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9hLWNocm9uaWNsZS1vZi1wZXJtdXRhdGlvbi1zdGF0aXN0aWNhbC1tZXRob2RzLTI4MDEzODMzNy5qcGc=","post_title":"A Chronicle of Permutation Statistical Methods","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319343822&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmathematik%2F447406%2Fa-chronicle-of-permutation-statistical-methods-1920-2000-and-beyond%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Preface.- 1.Introduction.- 2.1920-1939.- 2.1.Overview of Chapter 2.- 2.2.Neyman-Fisher-Geary and the Beginning.- 2.3.Fisher and the Variance-ratio Statistic.- 2.4.Eden-Yates and Non-normal Data.- 2.5.Fisher and 2 by 2 Contingency Tables.- 2.6 Yates and the Chi-squared Test for Small Samples.- 2.7.Irwin and Fourfold Contingency Tables.- 2.8.The Rothamsted Manorial Estate.- 2.9.Fisher and the Analysis of Darwin's Zea mays Data.- 2.10.Fisher and the Coefficient of Racial Likeness.- 2.11.Hotelling-Pabst and Simple Bivariate Correlation.- 2.12.Friedman and Analysis of Variance for Ranks.- 2.13.Welch's Randomized Blocks and Latin Squares.- 2.14.Egon Pearson on Randomization.- 2.15.Pitman and Three Seminal Articles.- 2.16.Welch and the Correlation Ratio.- 2.17.Olds and Rank-order Correlation.- 2.18.Kendall and Rank Correlation.- 2.19.McCarthy and Randomized Blocks.- 2.20.Computing and Calculators.- 2.21.Looking Ahead.- 3.1940-1959.- 3.1.Overview of Chapter 3.- 3.2.Development of Computing.- 3.3.Kendall-Babington Smith and Paired Comparisons.- 3.4.Dixon and a Two-sample Rank Test.- 3.5.Swed-Eisenhart and Tables for the Runs Test.- 3.6.Scheff\u00b4e and Non-parametric Statistical Inference.- 3.7.Wald-Wolfowitz and Serial Correlation.- 3.8.Mann and a Test of Randomness Against Trend.- 3.9.Barnard and 2 by 2 Contingency Tables.- 3.10.Wilcoxon and the Two-sample Rank-sum Test.- 3.11.Festinger and the Two-sample Rank-sum Test.- 3.12.Mann-Whitney and a Two-sample Rank-sum Test.- 3.13.Whitfield and a Measure of Ranked Correlation.- 3.14.Olmstead-Tukey and the Quadrant-sum Test.- 3.15.Haldane-Smith and a Test for Birth-order Effects.- 3.16.Finney and the Fisher-Yates Test for 2 by 2 Tables.- 3.17.Lehmann-Stein and Non-parametric Tests.- 3.18 Rank-order Statistics.- 3.19.van der Reyden and a Two-sample Rank-sum Test.-3.20.White and Tables for the Rank-sum Test.- 3.21.Other Results for the Two-sample Rank-sum Test.- 3.22.David-Kendall-Stuart and Rank-order Correlation.- 3.23.Freeman-Halton and an Exact Test of Contingency.- 3.24.Kruskal-Wallis and the C-sample Rank-sum Test.- 3.25.Box-Andersen and Permutation Theory.- 3.26.Leslie and Small Contingency Tables.- 3.27.A Two-sample Rank Test for Dispersion.- 3.28.Dwass and Modified Randomization Tests.- 3.29.Looking Ahead.- 4.1960-1979.- 4.1.Overview of Chapter 4.- 4.2.Development of Computing.- 4.3 Permutation Algorithms and Programs.- 4.4.Ghent and the Fisher-Yates Exact Test.- 4.5.Programs for Contingency Table Analysis.- 4.6.Siegel-Tukey and Tables for the Test of Variability.- 4.7 .Other Tables of Critical Values.- 4.8.Edgington and Randomization Tests.- 4.9.The Matrix Occupancy Problem.- 4.10.Kempthorne and Experimental Inference.- 4.11.Baker-Collier and Permutation F Tests 4.12.Permutation Tests in the 1970s.- 4.13.Feinstein and Randomization.- 4.14.The Mann-Whitney, Pitman, and Cochran Tests.- 4.15.Mielke-Berry-Johnson and MRPP.- 4.16.Determining the Number of Contingency Tables.- 4.17.Soms and the Fisher Exact Permutation Test.- 4.18.Baker-Hubert and Ordering Theory.- 4.19.Green and Two Permutation Tests for Location.- 4.20.Agresti-Wackerly-Boyett and Approximate Tests.- 4.21.Boyett and Random R by C Tables.- 4.22.Looking Ahead.- 5.1980-2000.- 5.1.Overview of Chapter 5.- 5.2.Development of Computing.- 5.3.Permutation Methods and Contingency Tables.- 5.4.Yates and 2 by 2 Contingency Tables.- 5.5.Mehta-Patel and a Network Algorithm.- 5.6.MRPP and the Pearson type III Distribution.- 5.7.MRPP and Commensuration.- 5.8.Tukey and Re randomization.- 5.9.Matched-pairs Permutation Analysis.- 5.10.Subroutine PERMUT.- 5.11.Moment Approximations and the F Test.- 5.12.Mielke-Iyer and MRBP.- 5.13.Relationships of MRBP to Other Tests.- 5.14.Kappa and the Measurement of Agreement.- 5.15.Basu and the Fisher Randomization Test.- 5.16.Still-White and Permutation Analysis of Variance.- 5.17.Walters and the Utility of Resampling Methods.- 5.18.Conover-Iman and Rank Transformations.- 5.19.Green and Randomization Tests.- 5.20.Gabriel-Hall and Re randomization Inference.- 5.21.Pagano-Tritchler and Polynomial-time Algorithms.- 5.22.Welch and a Median Permutation Test.- 5.23.Boik and the Fisher-Pitman Permutation Test.- 5.24.Mielke-Yao Empirical Coverage Tests.- 5.25.Randomization in Clinical Trials.- 5.26.The Period From 1990 to 2000.- 5.27.Algorithms and Programs.- 5.28.Page-Brin and Google.- 5.29.Spino-Pagano and Trimmed\/Winsorized Means.- 5.30.May-Hunter and Advantages of Permutation Tests.- 5.31.Mielke-Berry and Tests for Common Locations.- 5.32.Kennedy-Cade and Multiple Regression.- 5.33.Blair et al. and Hotelling's T2 Test.- 5.34.Mielke-Berry-Neidt and Hotelling's T2 Test.- 5.35.Cade-Richards and Tests for LAD Regression.- 5.36.Walker-Loftis-Mielke and Spatial Dependence.- 5.37.Frick on Process-based Testing.- 5.38.Ludbrook-Dudley and Biomedical Research.- 5.39.The Fisher Z Transformation.- 5.40.Looking Ahead.- 6.Beyond 2000.- 6.1.Overview of Chapter 6.- 6.2.Computing After Year 2000.- 6.3.Books on Permutation Methods.- 6.4.A Summary of Contributions by Publication Year.- 6.5.Agresti and Exact Inference for Categorical Data.- 6.6.The Unweighted Kappa Measure of Agreement.- 6.7.Mielke et al. and Combining Probability Values.- 6.8.Legendre and Kendall's Coefficient of Concordance.- 6.9.The Weighted Kappa Measure of Agreement.- 6.10.Berry et al. and Measures of Ordinal Association.- 6.11.Resampling for Multi-way Contingency Tables.- 6.12.Mielke-Berry and a Multivariate Similarity Test.- 6.13.Cohen's Weighted Kappa With Multiple Raters.- 6.14.Exact Variance of Weighted Kappa.- 6.15.Campbell and Two-by-two Contingency Tables.- 6.16.Permutation Tests and Robustness.- 6.17.Advantages of the Median for Analyzing Data.- 6.18.Consideration of Statistical Outliers.- 6.19.Multivariate Multiple Regression Analysis.- 6.20.O'Gorman and Multiple Linear Regression.- 6.21.Brusco-Stahl-Steinley and Weighted Kappa.- 6.22.Mielke et al. and Ridit Analysis.- 6.23.Knijnenburg et al. and Probability Values.- 6.24.Reiss et al. and Multivariate Analysis of Variance.- 6.25.A Permutation Analysis of Trend.- 6.26.Curran-Everett and Permutation Methods.- Epilogue.- References.- Acronyms.- Name Index.- Subject Index.","merchants_number":2,"ean":9783319343822,"category_id":103,"size":null,"min_price":111,"low_price_merchant_id":70255345,"ID":4882136,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"a-chronicle-of-permutation-statistical-methods","url":"\/unterhaltung\/produkt\/a-chronicle-of-permutation-statistical-methods\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 69.90
Probability and Statistics for Computer Science
1 Notation and conventions 9 1.0.1 Background Information........................................................................ 10 1.1 Acknowledgements................................................................................................. 11 I Describing Datasets ... zur Produkt-Seite
5051447 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvY2EvNzIvYWMvNjUwODE2MzYwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvY2EvNzIvYWMvNjUwODE2MzYwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9wcm9iYWJpbGl0eS1hbmQtc3RhdGlzdGljcy1mb3ItY29tcHV0ZXItc2NpZW5jZS0yNzUwOTE1OTIuanBn","post_title":"Probability and Statistics for Computer Science","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319644097&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmathematik%2F462878%2Fprobability-and-statistics-for-computer-science%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"1 Notation and conventions 9 1.0.1 Background Information........................................................................ 10 1.1 Acknowledgements................................................................................................. 11 I Describing Datasets , 12 2 First Tools for Looking at Data 13 2.1 Datasets....................................................................................................................... 13 2.2 What's Happening? - Plotting Data................................................................. 15 2.2.1 Bar 2.2.2 Histograms................................................................................................... 16 2.2.3 How to Make Histograms...................................................................... 17 2.2.4 Conditional Histograms.......................................................................... 19 2.3 Summarizing 1D Data............................................................................................ 19 2.3.1 The Mean...................................................................................................... 20 2.3.2 Standard Deviation................................................................................... 22 2.3.3 Computing Mean and Standard Deviation Online...................... 26 2.3.4 Variance......................................................................................................... 26 2.3.5 The Median.................................................................................................. 27 2.3.6 Interquartile Range.................................................................................. 29 2.3.7 Using Summaries Sensibly.................................................................... 30 2.4 Plots and Summaries............................................................................................. 31 2.4.1 Some Properties of Histograms.......................................................... 31 2.4.2 Standard Coordinates and Normal Data......................................... 34 2.4.3 Box Plots....................................................................................................... 38 2.5 Whose is bigger? Investigating Australian Pizzas...................................... 39 2.6 You should.................................................................................................................. 43 2.6.1 remember these definitions:................................................................. 43 2.6.2 remember these terms............................................................................ 43 2.6.3 remember these facts:............................................................................. 43 2.6.4 be able to...................................................................................................... 43 3 Looking at Relationships 47 3.1 Plotting 2D Data...................................................................................................... 47 3.1.1 3.1.2 Series.............................................................................................................. 51 3.1.3 Scatter Plots for Spatial Data.............................................................. 53 3.1.4 Exposing Relationships with Scatter Plots..................................... 54 3.2 Correlation.................................................................................................................. 57 3.2.1 The Correlation Coefficient................................................................... 60 3.2.2 Using Correlation to Predict................................................................ 64 3.2.3 Confusion caused by correlation......................................................... 68 1 3.4 You should.................................................................................................................. 72 3.4.1 remember these definitions:................................................................. 72 3.4.2 remember these terms............................................................................ 72 3.4.3 remember these facts: . . . . . 3.4.4 use these procedures: . . . . . . 3.4.5 be able to: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72 . . . . . . . . . . . . . . . . . 72 . . . . . . . . . . . . . . . . . 72 II Probability , 78 4 Basic ideas in probability 79 4.1 Experiments, Outcomes and Probability....................................................... 79 4.1.1 Outcomes and Probability...................................................................... 79 4.2 Events........................................................................................................................... 81 4.2.1 Computing Event Probabilities by Counting Outcomes............. 83 4.2.2 The Probability of Events...................................................................... 87 4.2.3 Computing Probabilities by Reasoning about Sets...................... 89 4.3 Independence............................................................................................................ 92 4.3.1 Example: Airline Overbooking............................................................ 96 4.4 Conditional ........................................................ 99 4.4.1 Evaluating Conditional Probabilities.............................................. 100 4.4.2 Detecting Rare Events is Hard......................................................... 104 4.4.3 Conditional Probability and Various Forms of Independence . 106 4.4.4 The Prosecutor's Fallacy 108 4.4.5 Example: The Monty Hall Problem................................................ 110 4.5 Extra Worked Examples.................................................................................... 112 4.5.1 Outcomes and Probability................................................................... 112 4.5.2 Events.......................................................................................................... 114 4.5.3 Independence........................................................................................... 115 4.5.4 Conditional Probability......................................................................... 117 4.6 You should............................................................................................................... 121 4.6.1 remember these definitions:.............................................................. 121 4.6.2 remember these terms......................................................................... 121 4.6.3 remember and use these facts.......................................................... 121 4.6.4 remember these points:....................................................................... 121 4.6.5 be able to.................................................................................................... 121 5 Random Variables and Expectations 128 5.1 Random Variables................................................................................................. 128 5.1.1 Joint and Conditional Probability for Random Variables . . . 131 5.1.2 Just a Little Continuous Probability............................................... 134 5.2 Expectations and Expected Values................................................................ 137 5.2.1 Expected Values...................................................................................... 138 5.2.2 Mean, Variance and Covariance....................................................... 141 5.2.3 Expectations and Statistics................................................................. 145 5.3 The Weak Law of Large Numbers................................................................ 145 5.3.1 IID Samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145 5.3.2 Two Inequalities . . . . . . . . . . . . . . . . . . . . . . . .. 146 5.3.3 Proving the Inequalities . . . . . . . . . . . . . . . . . . . . . 147 5.3.4 The Weak Law of Large Numbers.................................................. 149 5.4 Using the Weak Law of Large Numbers 151 5.4.1 Should you accept a bet?..................................................................... 151 5.4.2 Odds, Expectations and Bookmaking - a Cultural Diversion 152 5.4.3 Ending a Game Early 154 5.4.4 Making a Decision with Decision Trees and Expectations . . 154 5.4.5 Utility 156 5.5 You should................................................................................... 159 5.5.1 remember these definitions:.............................................................. 159 5.5.2 remember these terms......................................................................... 159 5.5.3 use and remember these facts.......................................................... 159 5.5.4 be able to.................................................................................................... 160 6 Useful Probability Distributions , 167 6.1 Discrete Distributions 167 6.1.1 The Discrete Uniform Distribution................................................. 167 6.1.2 Bernoulli Random Variables............................................................... 168 6.1.3 The Geometric Distribution................................................................ 168 6.1.4 The Binomial Probability Distribution........................................... 169 6.1.5 Multinomial probabilities..................................................................... 171 6.1.6 The Poisson Distribution..................................................................... 172 6.2 Continuous Distributions , 174 6.2.1 The Continuous Uniform Distribution........................................... 174 6.2.2 The Beta Distribution........................................................................... 174 6.2.3 The Gamma Distribution..................................................................... 176 6.2.4 The Exponential Distribution............................................................ 176 6.3 The Normal Distribution , 178 6.3.1 The Standard Normal Distribution................................................. 178 6.3.2 The Normal Distribution..................................................................... 179 6.3.3 Properties of The Normal Distribution......................................... 180 6.4 Approximating Binomials with Large N 182 6.4.1 Large N....................................................................................................... 183 6.4.2 Getting Normal6.4.3 Using a Normal Approximation to the Binomial Distribution 187 6.5 You should . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.5.1 remember these definitions: . . . . . . . . . . . . . . . . 6.5.2 remember these terms: . . . . . . . . . . . . . . . . . . . 6.5.3 remember these facts: . . . . . . . . . . . . . . . . . . . 6.5.4 remember these points: . . . . . . . . . . . . . . . . . . . . . 188 . . . 188 . . . 188 . . . 188 . . . 188 III Inference , 196 7 Samples and Populations 197 7.1 The Sample Mean................................................................................................. 197 7.1.1 The Sample Mean is an Estimate of the Population Mean . . 197 7.1.2 The Variance of the Sample Mean.................................................. 198 7.1.3 When The Urn Model Works............................................................ 201 7.1.4 Distributions are Like Populations................................................. 202 7.2 Confidence Intervals............................................................................................ 203 7.2.1 Constructing Confidence Intervals.................................................. 203 7.2.2 Estimating the Variance of the Sample Mean............................ 204 7.2.3 The Probability Distribution of the Sample Mean..................... 206 <,7.2.4 Confidence Intervals for Population Means................................. 208 7.2.5 Standard Error Estimates from Simulation................................. 212 7.3 You should............................................................................................................... 216 7.3.1 remember these definitions:.............................................................. 216 7.3.2 remember these terms......................................................................... 216 7.3.3 remember these facts:........................................................................... 216 7.3.4 use these procedures............................................................................. 216 7.3.5 be able to.................................................................................................... 216 8 The Significance of Evidence 221 8.1 Significance.............................................................................................................. 222 8.1.1 Evaluating Significance......................................................................... 223 8.1.2 P-values....................................................................................................... 225 8.2 Comparing the Mean of Two Populations.................................................. 230 8.2.1 Assuming Known Population Standard Deviations................... 231 8.2.2 Assuming Same, Unknown Population Standard Deviation . 233 8.2.3 Assuming Different, Unknown Population Standard Deviation 235 8.3 Other Useful Tests of Significance................................................................. 237 8.3.1 F-tests and Standard Deviations...................................................... 237 8.3.2 2 Tests of Model Fit............................................................................ 239 8.4 Dangerous Behavior............................................................................................. 244 8.5 You should............................................................................................................... 246 8.5.1 remember these definitions:.............................................................. 246 8.5.2 remember 8.5.3 remember these facts: . . . . . 8.5.4 use these procedures: . . . . . . 8.5.5 be able to: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246 . . . . . . . . . . . . . . . . . 246 . . . . . . . . . . . . . . . . . 246 9 Experiments , 251 9.1 A Simple Experiment: The Effect of a Treatment.................................. 251 9.1.1 Randomized Balanced Experiments............................................... 252 9.1.2 \u00a0 Decomposing Error in Predictions.................................................. 253 9.1.3 Estimating the Noise Variance......................................................... 253 9.1.4 The ANOVA Table.................................................................................. 255 9.1.5 Unbalanced Experiments.................................................................... 257 9.1.6 Significant Differences.......................................................................... 259 9.2 Two Factor Experiments.................................................................................... 261 9.2.1 , Decomposing the Error........................................................................ 264 9.2.2 Interaction Between Effects................................................................ 265 9.2.3 The Effects of a Treatment................................................................. 266 9.2.4 Setting up an ANOVA Table.............................................................. 267 9.3 You should............................................................................................................... 272 9.3.1 remember these definitions:.............................................................. 272 9.3.2 remember these terms......................................................................... 272 9.3.3 remember these facts:........................................................................... 272 9.3.4 use these procedures............................................................................. 272 9.3.5 be able to.................................................................................................... 272 9.3.6 Two-Way Experiments.......................................................................... 274 10 Inferring Probability Models from Data , 275 10.1 Estimating Model Parameters with Maximum Likelihood.................. 275 10.1.1 The Maximum Likelihood Principle............................................... 277 10.1.2 Binomial, Geometric and Multinomial Distributions................ 278 10.1.3 Poisson and Normal Distributions................................................... 281 10.1.4 Confidence Intervals for Model Parameters................................ 286 10.1.5 Cautions about Maximum Likelihood............................................ 288 10.2 Incorporating Priors with Bayesian Inference.......................................... 289 10.2.1 Conjugacy................................................................................................... 292 10.2.2 MAP Inference......................................................................................... 294 10.2.3 Cautions about Bayesian Inference................................................. 296 10.3 Bayesian Inference for Normal Distributions............................................ 296 10.3.1 Example: Measuring Depth of a Borehole................................... 296 10.3.2 Normal Prior and Normal Likelihood Yield Normal Posterior 297 10.3.3 Filtering...................................................................................................... 300 10.4 You should............................................................................................................... 303 10.4.1 remember these definitions:.............................................................. 303 10.4.2 remember these terms......................................................................... 303 10.4.3 remember these facts:........................................................................... 304 10.4.4 use these procedures............................................................................. 304 10.4.5 be able to.................................................................................................... 304 <,IV Tools 312 11 Extracting Important Relationships in High Dimensions 313 11.1 Summaries and Simple Plots........................................................................... 313 11.1.1 The Mean................................................................................................... 314 11.1.2 Stem Plots and Scatterplot Matrices.............................................. 315 11.1.3 Covariance.................................................................................................. 317 11.1.4 The Covariance Matrix......................................................................... 319 11.2 Using Mean and Covariance to Understand High Dimensional Data . 321 11.2.1 Mean and Covariance under Affine Transformations............... 322 11.2.2 . . 324 . . 325 . . 326 . . 327 . . 329 . 332 . . 334 . . 335 . . 335 . . 338 . . 339 . . 341 . . 345 . . 345 . . 345 . . 345 . . 345 . . 345 349 . . 349 . . 350 . . 350 . . 351 . . 351 . . 353 . . 355 . . 357 . . 358 . . 359 . . . 361 Eigenvectors and Diagonalization . . . . . . . . . . . . . . 11.2.3 Diagonalizing Covariance by Rotating Blobs . . . . . . . . 11.2.4 Approximating Blobs . . . . . . . . . . . . . . . . . . . . 11.2.5 Example: Transforming the Height-Weight Blob . . . . . 11.3 Principal Components Analysis . . . . . . . . . . . . . . . . . . . 11.3.1 Example: Representing Colors with Principal Components 11.3.2 Example: Representing Faces with Principal Components 11.4 Multi-Dimensional Scaling . . . . . . . . . . . . . . . . . . . . . . 11.4.1 Choosing Low D Points using High D Distances . . . . . . 11.4.2 Factoring a Dot-Product Matrix . . . . . . . . . . . . . . 11.4.3 Example: Mapping with Multidimensional Scaling . . . . 11.5 Example: Understanding Height and Weight . . . . . . . . . . . 11.6 You should . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11.6.1 remember these definitions: . . . . . . . . . . . . . . . . . 11.6.2 remember these terms: . . . . . . . . . . . . . . . . . . . . 11.6.3 remember these facts: . , . . . . . . . . . . . . . . . . . . . 11.6.4 use these procedures: . . . . . . . . . . . . . . . . . . . . . 11.6.5 be able to: . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Learning to Classify 12.1 Classification: The Big Ideas . . . . . . . . . . . . . . . . . . . . 12.1.1 The Error Rate . . . . . . . . . . . . . . . . . . . . . . . . 12.1.2 Overfitting . . . . . . . . . . . . . . . . . . . . . . . . . . 12.1.3 Cross-Validation . . . . . . . . . . . . . . . . . . . . . . . 12.1.4 Is the Classifier Working Well? . . . . . . . . . . . . . . . 12.2 Classifying with Nearest Neighbors . . . . . . . . . . . . . . . . . 12.3 Classifying with Naive Bayes . . . . . . . . . . . . . . . . . . . . 12.3.1 Missing Data . . . . . . . . . . . . . . . . . . . . . . . . . 12.4 The Support 12.4.1 Choosing a Classifier with the Hinge Loss . . . . . . . . . 12.4.2 Finding a Minimum: General Points . . . . . . . . . . . . 12.4.3 Finding a Minimum: Stochastic Gradient Descent . . . . 12.4.4 Example: Training an SVM with Stochastic Gradient Descent 363 12.4.5 Multi-Class Classification with SVMs.............................................. 366 12.5 Classifying with Random Forests................................................................... 367 12.5.1 Building a Decision Tree..................................................................... 367 12.5.2 Choosing a Split with Information Gain........................................ 370 12.5.3 Forests......................................................................................................... 373 12.5.4 Building and Evaluating a Decision Forest.................................. 374 12.5.5 Classifying Data Items with a Decision Forest........................... 375 12.6 You should............................................................................................................... 378 12.6.1 remember these definitions:.............................................................. 378 12.6.2 remember these terms......................................................................... 378 12.6.3 remember these facts:........................................................................... 379 12.6.4 use these procedures............................................................................. 379 12.6.5 be able to.................................................................................................... 379 13.1 The Curse of Dimension..................................................................................... 384 13.1.1 The Curse: Data isn't Where You Think it is............................. 384 13.1.2 Minor Banes of Dimension.................................................................. 386 13.2 The Multivariate Normal Distribution......................................................... 387 13.2.1 Affine Transformations and Gaussians.......................................... 387 13.2.2 Plotting a 2D Gaussian: Covariance Ellipses.............................. 388 13.3 Agglomerative and Divisive Clustering........................................................ 389 13.3.1 Clustering and Distance....................................................................... 391 13.4 , The K-Means Algorithm and Variants......................................................... 392 13.4.1 How to choose K...................................................................................... 395 13.4.2 Soft Assignment....................................................................................... 397 13.4.3 General Comments on K-Means....................................................... 400 13.4.4 K-Mediods.................................................................................................. 400 13.5 Application Example: Clustering Documents........................................... 401 13.5.1 A Topic Model.......................................................................................... 402 13.6 Describing Repetition with Vector Quantization...................................... 403 13.6.1 Vector Quantization............................................................................... 404 13.6.2 Example: Groceries in Portugal....................................................... 406 13.6.3 Efficient Clustering and Hierarchical K Means.......................... 409 13.6.4 Example: Activity from Accelerometer Data............................... 409 13.7 You should............................................................................................................... 413 13.7.1 remember these definitions:.............................................................. 413 13.7.2 remember these terms......................................................................... 413 13.7.3 remember these facts:........................................................................... 413 13.7.4 use these procedures............................................................................. 413 14 Regression , 417 14.1.1 Regression to Make Predictions....................................................... 417 14.1.2 Regression to Spot Trends.................................................................. 419 14.1 Linear Regression and Least Squares.......................................................... 421 14.1.1 Linear Regression................................................................................... 421 14.1.2 Choosing beta.................................................................................................. 422 14.1.3 Solving the Least Squares Problem................................................ 423 14.1.4 , Residuals..................................................................................................... 424 14.1.5 R-squared.................................................................................................... 424 14.2 Producing Good Linear Regressions............................................................. 427 14.2.1 Transforming Variables........................................................................ 428 14.2.2 Problem Data Points have Significant Impact............................ 431 14.2.3 Functions of One Explanatory Variable........................................ 433 14.2.4 Regularizing Linear Regressions...................................................... 435 14.3 , Exploiting Your Neighbors 14.3.1 Using your Neighbors to Predict More than a Number............ 441 14.3.2 Example: Filling Large Holes with Whole Images.................... 441 14.4 You should . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.4.1 remember these definitions: . . . . . . . . . . . . . . 14.4.2 remember these terms: . . . . . . . . . . . . . . . . . . . . . . 444 . . . . . 444 . . . . . 444 14.4.3 remember these facts:........................................................................... 444 14.4.4 remember these procedures:............................................................. 444 15 Markov Chains and Hidden Markov Models , 454 15.1 Markov Chains........................................................................................................ 454 15.1.1 Transition Probability Matrices........................................................ 457 15.1.2 Stationary Distributions....................................................................... 459 15.1.3 Example: Markov Chain Models of Text...................................... 462 15.2 Estimating Properties of Markov Chains.................................................... 465 15.2.1 Simulation.................................................................................................. 465 15.2.2 Simulation Results as Random Variables..................................... 467 15.2.3 Simulating Markov Chains.................................................................. 469 15.3 Example: Ranking the Web by Simulating a Markov Chain................ 472 15.4 Hidden Markov Models and Dynamic Programming............................. 473 15.4.1 Hidden Markov Models........................................................................ 474 15.4.2 Picturing Inference with a Trellis.................................................... 474 15.4.3 Dynamic Programming for HMM's: Formalities....................... 478 15.4.4 , Example: Simple Communication Errors..................................... 478 15.5 You should............................................................................................................... 481 15.5.1 remember these definitions:.............................................................. 481 15.5.2 remember these terms......................................................................... 481 15.5.3 remember these facts:........................................................................... 481 15.5.4 be able to.................................................................................................... 481 V Some Mathematical Background , 484 16 Resources 485 16.1 Useful Material about Matrices....................................................................... 485 16.1.1 The Singular Value Decomposition................................................. 486 16.1.2 Approximating A Symmetric Matrix............................................... 487 16.2 Some Special Functions..................................................................................... 489 16.3 Finding Nearest Neighbors............................................................................... 490 16.4 Entropy and Information Gain........................................................................ 493","merchants_number":2,"ean":9783319644097,"category_id":103,"size":null,"min_price":69.900000000000005684341886080801486968994140625,"low_price_merchant_id":70255345,"ID":5051447,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"probability-and-statistics-for-computer-science","url":"\/unterhaltung\/produkt\/probability-and-statistics-for-computer-science\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 111.00
Clinical Anesthesia
Table of Contents 1 Case 1: No Fibro-Optic Intubation System - A Potential Problem 2 Case 2: Is the Patient Extubated? 3 Case 3: A Strange Computerized ECG Interpretation 4 Case 4: An Elderly Lady with a Fractured Neck of Femur 5 Case 5: A Spinal Anesthetic That Wears Off Before Surgery Ends. What to Do? 6 Case 6: Just a Si... zur Produkt-Seite
4123106 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvNTMvZDQvNmEvNjY2NzE4NDQwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvNTMvZDQvNmEvNjY2NzE4NDQwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9jbGluaWNhbC1hbmVzdGhlc2lhLTMyNTM1MzgwMi5qcGc=","post_title":"Clinical Anesthesia","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319714660&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmedizin-pharmazie%2F464812%2Fclinical-anesthesia-near-misses-and-lessons-learned%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Table of Contents 1 Case 1: No Fibro-Optic Intubation System - A Potential Problem 2 Case 2: Is the Patient Extubated? 3 Case 3: A Strange Computerized ECG Interpretation 4 Case 4: An Elderly Lady with a Fractured Neck of Femur 5 Case 5: A Spinal Anesthetic That Wears Off Before Surgery Ends. What to Do? 6 Case 6: Just a Simple Monitored Anesthesia Care (MAC) Case 7 Case 7: Smell of Burning in the Operating Room 8 Case 8: A Diabetic Patient for Inguinal Hernia Repair 9 Case 9: The Case of the \"Hidden\" IV 10 Case 10: Postoperative Painful Eye 11 Case 11: Awake Craniotomy 12 Case 12: Gum Elastic Bougie 13 Case 13: You Smell Anesthesia Vapor. Where Is It Coming From? 14 Case 14: Manual Ventilation of a Patient Turned 180 Degrees Away From the Anesthesia Machine by a Single Operator. Is It Possible? 15 Case 15: Life Threatening Arrhythmia in a 5 Month Old 16 Case 16: Tongue Ring 17 Case 17: Hasty C-Arm Positioning. A Recipe for Disaster. 18 Case 18: Inability to Remove a Nasogastric Tube 19 Case 19: An Unusual Cause of Difficult Tracheal Intubation 20 Case 20: Pulmonary Edema Following Abdominal Laparoscopy 21 Case 21: A Possible Solution to a Difficult Laryngeal Mask Airway Placement 22 Case 22: Postoperative Airway Complication Following Sinus Surgery 23 Case 23: An Unusual Capnograph Tracing 24 Case 24: A Respiratory Dilemma during a Transjugular Intrahepatic Porto-Systemic Shunt Procedure (TIPSS) 25 Case 25: A Tracheotomy is Urgently Needed and You Have Never Done One 26 Case 26: General Anesthesia for a Patient with a Difficult Airway and Full Stomach 27 Case 27: A Jehovah's Witness Patient and a Potentially Bloody Operation 28 Case 28: Laparoscopic Achalasia Surgery 29 Case 29: Sudden Intraoperative Hypotension 30 Case 30: Blood Pressure Difference between a Non-Invasive and an Invasive Blood Pressure Measurement 31 Case 31: Severe Decrease in Lung Compliance during a Code Blue 32 Case 32: Shortening Post-Anesthesia Recovery Time after an Epidural. Is It Possible? 33 Case 33: At Times You Need To Be a MacGyver 34 Case 34: Delayed Cutaneous Fluid Leak from a Puncture Hole after Removal of an Epidural Catheter 35 Case 35: Traumatic Hemothorax and Same Side Central Venous Access 36 Case 36: A Single Abdominal Knife Wound. Easy Case? 37 Case 37: A Draw-Over Vaporizer with a Non-Rebreathing Circuit 38 Case 38: Unexpected Intraoperative \"Oozing\" 39 Case 39: Central Venous Access and the Obese Patient 40 Case 40: Check Your Facts 41 Case 41: Intraoperative Epidural Catheter Malfunction 42 Case 42: Breathing Difficulties after an ECT 43 Case 43: White \"Clumps\" in the Blood Sample from an Arterial Line 44 Case 44: Anesthesia for a Surgeon Who Has Previously Lost His Privileges 45 Case 45: Airway Obstruction in an Anesthetized Prone Patient 46 Case 46: A Question You Should Always Ask 47 Case 47: Postoperative Vocal Cord Paralysis 48 Case 48: This Is a Serious Problem 49 Case 49: A Leaking Endotracheal Tube in a Prone Patient 50 Case 50: An Impossible Situation? 51 Case 51: An \"Old Trick\" But a Potential Serious Problem 52 Case 52: A Loud \"Pop\" Intra-Operatively and Now You Can't Ventilate 53 Case 53: Postoperative Median Nerve Injury 54 Case 54: A Patient in a Halo 55 Case 55: It Is Now or Never 56 Case 56: General Anesthesia in a Patient with Daily Use of Prescribed Amphetamine 57 Case 57: What Is Wrong With This Picture? 58 Case 58: The One-Eyed Patient 59 Case 59: A Near Tragedy 60 Case 60: Robot Assisted Surgery. A Word of Caution. 61 Case 61: An Airway Emergency in an Out of Hospital Surgical Office 62 Case 62: A Case of Recent Hip Replacement Coming For a Cystoscopy 63 Case 63: A High Glucose Concentration in an Epidural Catheter Aspirate. Should One Be Concerned? 64 Case 64: A General Anesthesia in a Patient Who Has Had a Recent Eye Operation 65 Case 65: Another Awake Craniotomy 66 Case 66: Spinal Fracture and Flail-Segment Rib Fractures Following a Motor Vehicle Accident 67 Case 67: Angioedema in the Emergency Department 68 Case 68: Cranioplasty. Should You Be Concerned? 69 Case 69: More Haste Less Speed 70 Case 70: A Pregnant Patient for a Carpal Tunnel Operation 71 Case 71: A Request to Provide Isoflurane Anesthesia for Treatment of Status Epilepticus 72 Case 72: No Methylene Blue in the Urine. What Would You Do? 73 Case 73: A Right Upper-Lobe Tumor and Concurrent Tracheal Polyp. What Lung Isolation Technique Would You Use? 74 Case 74: Complete Heart Block during Central Line Placement 75 Case 75: Cervical Hematoma Following Neck Surgery 76 Case 76: Transient Language Disturbance Following General Anesthesia 77 Case 77: A Flexible Suction Catheter Complication 78 Case 78: A Neurosurgical Case with a Sudden Disappearance of the Arterial Line Waveform 79 Case 79: Not Another Corneal Abrasion 80 Case 80: A Maxillofacial Operation 81 Case 81: A Patient with a Transplanted Heart for Cholecystectomy 82 Case 82: A High Total Spinal in an Obstetric Patient 83 Case 83: Peroral Endoscopic Myotomy (POEM) 84 Case 84: A Neonatal Emergency 85 Case 85: This Could Be Serious 86 Case 86: A Case of Acoustic Neuroma 87 Case 87: Is the IV Infiltrated? 88 Case 88: Communication is Essential 89 Case 89: Watch Out 90 Case 90: A Simple Case but it Goes On and On 91 Case 91: Endotracheal Intubation in the ICU. Watch Out. 92 Case 92: A Straight Forward Case, or Is It? 93 Case 93: Postoperative Red Urine 94 Case 94: Patient's Toes Suddenly Become White during a Lower Limb Operation 95 Case 95: A Percutaneous Tracheostomy 96 Case 96: A Patient in the Prone Position. Watch Out. 97 Case 97: A Patient with Obstructive Sleep Apnea 98 Case 98: A Case of Wegener Granulomatosis 99 Case 99: What Can Possibly Go Wrong? 100 Case 100: Severe Case of Hyperkalemia during Rapid Blood Transfusion 101 Case 101: A Monitor is Just a Machine 102 Case 102: A Case of Preoperative Sinus Tachycardia 103 Case 103: Bonus Question","merchants_number":2,"ean":9783319714660,"category_id":103,"size":null,"min_price":111,"low_price_merchant_id":70255345,"ID":4123106,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"clinical-anesthesia","url":"\/unterhaltung\/produkt\/clinical-anesthesia\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 118.00
Advances in Information Retrieval
Keynotes.- Still Haven't Found What I'm Looking For: Suggestions for Search Research.- Mining and Modeling Online Health Search.- What to do if you know everything? Studying human behavior in a virtual world.- Aggregated Search and Diversity.- Towards Query Level Resource Weighting For Diversified Query Expansion.- Exploring Composite Retrieval from the Users' Perspective.- Improving ... zur Produkt-Seite
4749101 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9pLndlbHRiaWxkLmRlL3AvYWR2YW5jZXMtaW4taW5mb3JtYXRpb24tcmV0cmlldmFsLTI3ODgxMzU4NC5qcGc=!aHR0cHM6Ly9pLndlbHRiaWxkLmRlL3AvYWR2YW5jZXMtaW4taW5mb3JtYXRpb24tcmV0cmlldmFsLTI3ODgxMzU4NC5qcGd8fnxodHRwczovL29zMS5tZWluZWNsb3VkLmlvL2IxMDE1OC9tZWRpYS9pbWFnZS9kMS8yYS85ZC81MTM1MjkyNzAwMDAxQV82MDB4NjAwLmpwZw==","post_title":"Advances in Information Retrieval","deeplink":"https:\/\/track.adtraction.com\/t\/t?a=1632201226&as=1592767275&t=2&tk=1&url=https:\/\/www.weltbild.ch\/artikel\/x\/_20152349-1","labels":[],"brand_id":1,"post_content":"Keynotes.- Still Haven't Found What I'm Looking For: Suggestions for Search Research.- Mining and Modeling Online Health Search.- What to do if you know everything? Studying human behavior in a virtual world.- Aggregated Search and Diversity.- Towards Query Level Resource Weighting For Diversified Query Expansion.- Exploring Composite Retrieval from the Users' Perspective.- Improving Aggregated Search Coherence.- On-topic Cover Stories from News Archives.- Classification.- Multi-Emotion Detection in User-Generated Reviews.- Classification of historical notary acts with noisy labels.- ConceptFusion: A Flexible Scene Classification Framework.- An Audio-Visual Approach to Music Genre Classiffcation through Affective Color Features.- Cross-Lingual and Discourse.- Multi-Modal Correlated Centroid Space for Multi-Lingual Cross-Modal Retrieval.- A Discourse Search Engine based on Rhetorical Structure Theory.- Knowledge-based Representation for Transductive Multilingual Document Classiffcation.- Distributional Correspondence Indexing for Cross-Language Text Categorization.- Effciency Adaptive Caching of Fresh Web Search Results.- Approximating Weighted Hamming Distance by Probabilistic Selection for Multiple Hash Table.- Graph Regularised Hashing.- Approximate Nearest-Neighbour Search with Inverted Signature Slice Lists.- Evaluation.- A Discriminative Approach to Predicting Assessor Accuracy.- WHOSE A Tool for Whole-Session Analysis in IIR.- Looking for Books in Social Media: An Analysis of Complex Search Requests.- How do Gain and Discount Functions Affect the Correlation between DCG and User Satisfaction?.- Different Rankers on Different Subcollections.- Retrievability Bias: A Comparison of Inequality Measures.- Judging Relevance Using Magnitude Estimation.- Event Mining and Summarisation.- Retrieving Time from Scanned Books.- A Noise-Filtering Approach for Spatio-Temporal Event Detection in Social Media.- Timeline Summarization from Relevant Headlines.- Information Extraction.- A Self-Training CRF Method for Recognizing Product Model Mentions in Web Forums.- Information Extraction Grammars.- Target-based Topic Model for Problem Phrase Extraction.- On Identifying Phrases Using Collection Statistics.- MIST: Top-k Approximate Sub-String Mining using Triplet Statistical Significance.- Recommender Systems.- Active Learning applied to Rating Elicitation for Incentive Purposes.- Entity-Centric Stream Filtering and ranking: Filtering and Unfilterable Documents.- Generating Music Playlists with Hierarchical Clustering and Q-Learning.- Time-sensitive Collaborative Filtering through Adaptive Matrix Completion.- Toward the New Item Problem: Context-enhanced Event Recommendation in Event-based Social Networks.- On the Infence of User Characteristics on Music Recommendation Algorithms.- A Study of Smoothing Methods for Relevance-Based Language Modelling of Recommender Systems.- The Power of Contextual Suggestion.- Semantic and Graph-Based Models.- Exploiting Semantic Annotations for Domain-Specific Entity Search.- Reachability Analysis of Graph Modelled Collections.- Main Core Retention on Graph-of-words for Single-Document Keyword Extraction.- Entity Linking for Web Search Queries.- Sentiment and Opinion.- Beyond Sentiment Analysis: Mining Defects and Improvements from Customer Feedback.- Measuring User Infuence, Susceptibility and Cynicalness in Sentiment Diffusion.- Automated Controversy Detection on the Web.- Learning Sentiment Based Ranked-Lexicons for Opinion Retrieval.- Topic-dependent sentiment classification on Twitter.- Learning Higher-Level Features with Convolutional Restricted Boltzmann Machines for Sentiment Analysis.- Social Media.- Towards Deep Semantic Analysis of Hashtags.- Chalk and Cheese in Twitter: Discriminating Personal and Organization Accounts.- Handling Topic Drift for Topic Tracking in Microblogs.- Detecting Location-centric Communities using Social-Spatial Links with Temporal Constraints.- Using Subjectivity Analysis to Improve Thread Retrieval in Online Forums.- Selecting Training Data for Learning-based Twitter Search.- Content-Based Similarity of Twitter Users.- Specific Search Tasks.- A Corpus of Realistic Known-Item Topics With Associated Web Pages in the ClueWeb09.- Designing States, Actions, and Rewards for Using POMDP in Session Search.- Retrieving Medical Literature for Clinical Decision Support.- PatNet: A lexical database for the patent domain.- Learning to Rank Aggregated Answers for Crossword Puzzles.- Diagnose This If You Can: On the effectiveness of search engines in Finding medical self-diagnosis information.- Sources of Evidence for Automatic Indexing of Political Texts.- Automatically Assessing Wikipedia Article Quality by Exploiting Article-Editor Networks.- Temporal Models and Features.- Long time, no tweets! Time-aware personalised hashtag suggestion.- Temporal Multinomial Mixture for Instance-oriented Evolutionary Clustering.- Temporal Latent Topic User Profiles for Search Personalisation.- Document Priors Based On Time-Sensitive Social Signals.- Topic and Document Models.- Prediction of Venues in Foursquare using Flipped Topic Models.- Geographical Latent Variable Models for Microblog Retrieval.- Nonparametric Topic Modeling using Chinese Restaurant Franchise with Buddy Customers.- A Hierarchical Tree Model for Update Summarization.- Document Boltzmann Machines for Information Retrieval.- Effective Healthcare Advertising using Latent Dirichlet Allocation and Inference Engine.- User Behavior.- User simulations for interactive search: evaluating personalized query Suggestion.- The Impact of Query Interface Design on Stress, Workload and Performance.- Detecting Spam URLs in Social Media via Behavioral Analysis.-Predicting Re-Finding Activity and Diffculty.- User Behavior in Location Search on Mobile Devices.- Detecting the Eureka Effect in Complex Search.- Reproducible IR.- Twitter Sentiment Detection via Ensemble Classification Using.- Averaged Confidence Scores.- Reproducible Experiments on Lexical and Temporal Feedback for Tweet Search.- Rank-Biased Precision Reloaded: Reproducibility and Generalization.- Demonstrations.- Knowledge Journey Exhibit: Towards Age-Adaptive Search User Interfaces.- PopMeter: Linked-Entities in a Sentiment Graph.- Adaptive Faceted Ranking for Social Media Comments.- Signal: Advanced real-time information Filtering.- The iCrawl Wizard Supporting Interactive Focused Crawl Specification.- Linguistically-enhanced search over an open diachronic corpus.- From Context-Aware to Context-Based: Mobile Just-In-Time Retrieval of Cultural Heritage Objects.- Tutorials.- Visual Analytics for Information Retrieval Evaluation (VAIR?E 2015).- Measuring Document Retrievability.- A Formal Approach to Effectiveness Metrics for Information Access: Retrieval, Filtering, and Clustering.- Statistical Power Analysis for Sample Size Estimation in Information Retrieval Experiments with Users.- Join the Living Lab: Evaluating News Recommendations in Real-time.- Workshops.- 5th Workshop on Context-awareness in Retrieval and Recommendation (CaRR 2015).- Multimodal Similar Case Retrieval in the Medical Domain.- Second International Workshop on Gamification for Information.- Retrieval (GamifIR).- Supporting Complex Search Tasks.- Bibliometric-enhanced Information Retrieval: 2nd International BIR Workshop.","merchants_number":2,"ean":9783319163536,"category_id":103,"size":null,"min_price":118,"low_price_merchant_id":27291482,"ID":4749101,"merchants":["weltbild","euniverse"],"brand":"undefined","slug":"advances-in-information-retrieval-3","url":"\/unterhaltung\/produkt\/advances-in-information-retrieval-3\/","low_price_merchant_name":"Weltbild"}
Produkt merken zur Merkliste CHF 111.00
Fostering Creativity and Innovation
Table of Contents 1 1.1 Introduction to Organizational Creativity and Innovation 1.2 Challenges of Global Entrepreneurship 1.3 Concepts of Design thinking 1.4 Shaping Innovation Deployment 1.5 The Ideation Process and Tools 1.6 Importance of Innovation in UAE 1.7 Innovation Legacy: The Case of the United Arab Emirates Synopsis: This c... zur Produkt-Seite
5110403 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZGQvNjkvMmMvNzEzOTc4NDMwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZGQvNjkvMmMvNzEzOTc4NDMwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9mb3N0ZXJpbmctY3JlYXRpdml0eS1hbmQtaW5ub3ZhdGlvbi0yNzM1ODI5MjcuanBn","post_title":"Fostering Creativity and Innovation","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319991207&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fsozialwissenschaften-recht-wirtschaft%2Fwirtschaft%2F478238%2Ffostering-creativity-and-innovation-creating-a-sustainable-innovation-environment-in-the-united-ara%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"\u00a0 Table of Contents 1 \u00a0 1.1 Introduction to Organizational Creativity and Innovation 1.2 Challenges of Global Entrepreneurship 1.3 Concepts of Design thinking 1.4 Shaping Innovation Deployment 1.5 The Ideation Process and Tools 1.6 Importance of Innovation in UAE 1.7 Innovation Legacy: The Case of the United Arab Emirates \u00a0 Synopsis: This chapter thus illustrates the pitfalls for building a strong foundation for creativity and innovation in organisations. It also discusses the four big questions of what innovation deployment is, why we use it, how it works, and who shapes it. This is followed by a discussion of the innovation legacy of the United Arab Emirates (UAE), which ranked 35th on the 2017 Global Innovation Index and 16th in the 2017 Global Competitiveness Report. The chapter then describes the importance of innovation in UAE and introduces the UAE Innovation Award and explains how the quest for innovation has evolved over the years. Theoretical models of creativity and innovation, as well as evolution and ideation tools, are also discussed. Organizations that shed their rigidity are continually adapting and learning from within their organizations as well as from others. In recent years, research has suggested that innovation and creativity have become pillars for leveraging competitive advantage. Though the terms \"innovation\" and \"creativity\" are discussed together at times, they are defined separately. Hence, it is essential to understand these terms along with their implications for global entrepreneurs. More importantly, the success with innovation and creativity has come in many shapes and forms. 2 Part 2: TQM, AMO, Innovation and Factors Impacting Organizational Creativity and Innovation \u00a0 2.1\u00a0\u00a0 Theoretical Underpinnings\u00a0 2.2\u00a0\u00a0 Transition from Quality to Innovation 2.3\u00a0\u00a0 Bringing in Tools: What can we learn from \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 TQM to Innovate? 2.4\u00a0\u00a0 Innovation and Change 2.5\u00a0\u00a0 Power of Ability, Opportunity and Motivation(AMO) 2.6\u00a0\u00a0 Factors impacting creativity and Innovation Synopsis: General managers and entrepreneurs share a keen interest in learning how to foster innovation and creativity in ways that help their firms create wealth. In examining the various innovation contexts, it is clear that some organizational cultures produce many more innovations than others. Human beings are fundamentally creative, however, individuals can be nurtured further to produce creative ideas. Entrepreneurs need to understand how to achieve those creative outcomes that can result in organizations emerging as successful enterprises. This chapter aims to recognise factors that entrepreneurs should embrace in their organization and explains its theoretical underpinnings to the ability, opportunity, motivation (AMO), and Total Quality Management. 3 Part 3: A Framework for Innovation Assessment \u00a0 \u00a03.1 Enablers and Outcomes \u00a03.2 Leadership\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a03.3 People \u00a03.4 Capability: Organizational Support and Resources \u00a03.5 Evaluation and Rewards\u00a0 \u00a03.6 Innovation Effectiveness\u00a0\u00a0\u00a0 Synopsis: The goal of the assessment is to identify the problems or opportunities that can be addressed through an evaluation. This chapter introduces the assessment framework to carry out an evaluation of an organisation's level of creativity and innovation. The assessment model includes five criteria: leadership, people, capability, evaluation and rewards, and innovation effectiveness. Each of these criteria are discussed in this chapter along with a case study. This chapter thus helps the reader understand what factors to address in order to leverage the results of innovation and to build enthusiasm for improvement. 4 \u00a0 Part 4: \"How Are We Doing\"? Using a Maturity Model Assessment \u00a0 4.1 Maturity Model Structure 4.2 Innovation and Creativity Assessment Tool (ICAT) 4.3 How to Use the ICAT and the Maturity Model 4.4 Measuring Progress and Success Using the ICAT 4.5 Defining Your Path to Success Synopsis: This chapter focuses on helping organisations evaluate how far tan organization has \u00a0on \u00a0an innovation deployment drive and to chart a path forward. For doing so, we introduce a maturity model and the innovation and creativity assessment tool (ICAT). The five components discussed in the previous chapter make up the most important elements of the model, which uses three levels of achievement, or maturity, from grassroots efforts with ad hoc projects to world class deployment. The chapter provides advice on how to use this structured tool to address critical questions such as: Do we have the right pieces in place? Is anything missing? What are we doing well? What are our challenges? What's most important for us to work on next? 5 Part 5: Innovation in Action \u00a0 5.1 Innovation Assessments 5.2 Innovation Awards 5.3 Preparing to Embrace Innovation Culture 5.4 Leading for innovation: What it is and what it is not \u00a0 Synopsis: In this chapter, we focus on understanding global frameworks and the structure of innovation assessments. Our aim is also to help the reader understand various innovation awards and how to write a strong application for such awards. We conclude by analyzing how such frameworks are becoming relevant in today's constantly changing market, and why it has become necessary for organisations to deploy these frameworks to gain a competitive advantage in both local and global markets. The chapter illustrates a few case scenarios about organisations who win innovation awards and continuously leverage their human capital towards the drive for innovation. 6 Part 6: Sustaining Innovation and Future research implications \u00a0 6.1 Cases of Winning Innovation Profiles 6.2 Learning from Wining Innovations 6.3 Sustaining Innovation 6.4 Emerging research streams in innovation \u00a0 Synopsis: In this section, we introduce case studies in innovation where the emphasis is on the role and importance of innovation enablers in achieving results. Four organisations representing the private and public sectors highlight how to shape a high-performing culture of innovation. The chapter discusses the various strategies that can help organisations achieve results. We conclude by presenting an analysis of the four cases, and we reiterate the importance of sustainable innovations for organisations globally. We identify and envisage that, when it comes to innovation results, the focus has to be on the four key areas of profitability, sustainability, reputation, and governance. Further, we debate that to be successful, creativity-the ability to conceive and implement novel initiatives-becomes crucial for organisations to remain sustainably competitive. In concluding section, we will also focus on discussing the emerging research themes for future research and present new research prepositions.","merchants_number":2,"ean":9783319991207,"category_id":103,"size":null,"min_price":111,"low_price_merchant_id":70255345,"ID":5110403,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"fostering-creativity-and-innovation","url":"\/unterhaltung\/produkt\/fostering-creativity-and-innovation\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 211.00
Circulating Nucleic Acids in Serum and Plasma - CNAPS IX
Foreword Peter B. Gahan, Michael Fleischhacker, Bernd Schmidt .- Part I Nucleic Acids in Oncology - prognosis, treatments screening and metastases .- 1 Circulating Cell-free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer Xiaodan Meng, Volkmar Müller, Karin Milde-Langosch, Fabian Trillsch, Klaus Pantel, Heidi Schwarzenbach.- 2 Cell-free miRNA-141... zur Produkt-Seite
4174511 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvY2EvMzAvYWEvNTgxNzUzOTQwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvY2EvMzAvYWEvNTgxNzUzOTQwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9jaXJjdWxhdGluZy1udWNsZWljLWFjaWRzLWluLXNlcnVtLWFuZC1wbGFzbWEtY25hcHMtMzI4MDA3NjMyLmpwZw==","post_title":"Circulating Nucleic Acids in Serum and Plasma - CNAPS IX","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319420424&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmedizin-pharmazie%2F450406%2Fcirculating-nucleic-acids-in-serum-and-plasma-cnaps-ix%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Foreword Peter B. Gahan, Michael Fleischhacker, Bernd Schmidt .- Part I\u00a0\u00a0 Nucleic Acids in Oncology - prognosis, treatments screening and metastases .- 1 Circulating Cell-free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer Xiaodan Meng, Volkmar M\u00fcller, Karin Milde-Langosch, Fabian Trillsch, Klaus Pantel, Heidi Schwarzenbach.- 2 \u00a0Cell-free miRNA-141 and miRNA-205 as Prostate Cancer Biomarkers Ivan D. Osipov, Ivan A. Zaporozhchenko, Anna A. Bondar, Marat M. Zaripov, Vladimir E. Voytsitskiy, Valentin V. Vlassov, Pavel P. Laktionov, Evgeny S. Morozkin.- 3 Clinical utility of circulating tumor DNA for molecular assessment and precision medicine in pancreatic cancer Erina Takai, Yasushi Totoki, Hiromi Nakamura, Mamoru Kato, Tatsuhiro Shibata, Shinichi Yachida.- 4 An Enquiry Concerning the Characteristics of Cell-free DNA Released by Cultured Cancer Cells \u00a0Abel J Bronkhorst, Johannes F Wentzel, Janine Aucamp, Etresia van Dyk, Lissinda du Plessis, Piet J Pretorius .-\u00a05 Detection of p53 Mutations in Circulating DNA of Transplanted Hepatocellular Carcinoma Patients as a Biomarker of Tumor Recurrence Noelia Garc\u00eda-Fern\u00e1ndez , Hada Macher, Amalia Rubio, Pilar Jim\u00e9nez-Arriscado, Bernal-Bellido C,\u00a0 Bellido-D\u00edaz ML, Gonzlo Su\u00e1rez-Artacho, Juan M. Guerrero, Miguel A. G\u00f3mez-Bravo, Patrocinio Molinero .- 6 Unbiased Detection of Somatic Copy Number Aberrations in cfDNA of Lung Cancer Cases and High-risk Controls with Low Coverage Whole Genome sequencing Fiona Taylor, James Bradford, Penella J. Woll, Dawn Teare, Angela Cox.- 7 Liquid Profiling in Lung Cancer - Quantification of Extracellular miRNAs in Bronchial Lavage Bernd Schmidt, Grit Rehbein, Michael Fleischhacker.- 8 Screening of KRAS Mutation in Pre- and Post-surgery Serum of Patients Suffering from Colon Cancer by COLD-PCR HRM Elena Trujillo-Arribas, Hado C. Macher, Pilar Jim\u00e9nez-Arriscado, Fernando de la Portilla, Patrocinio Molinero, Juan M. Guerrero, Amalia Rubio.- 9 Non-Dividing Cell Virtosomes Affect in vitro and in vivo Tumour Cell Replication Mariano Garcia-Arranz, Damian Garcia-Olmo, Luz Vega-Clemente, Maurice Stroun, Peter B. Gahan.- \u00a010 Features of Circulating DNA Fragmentation in Blood of Healthy Females and Breast Cancer Patients Svetlana N. Tamkovich, Natalia A. Kirushina, Vladimir E. Voytsitskiy, Pavel P. Laktionov.- 11 Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer Patients Stefan Holdenrieder.- Part II CNAPS in foetal medicine.- 12 Characterization of Human Pregnancy Specific Glycoprotein (PSG) Gene Copy Number Variations in Pre-eclampsia Patients Chia Lin Chang, Chia Yu Chang,\u00a0\u00a0Da Xian Lee, Po Jen Cheng.- 13 Non-Invasive Prenatal Diagnosis of Fetal-Maternal Platelet Incompatability by Cold High Resolution Melting Analysis Marta Ferro, Hada C. Macher, Pilar Noguerol, Pilar Jimenez-Arriscado, Patrocinio Molinero, Juan M. Guerrero, Amalia Rubio.- 14 Implementing Non-invasive Prenatal Diagnosis (NIPD) in a National Health Service Laboratory, from Dominant to Recessive Disorders Suzanne Drury, Sarah Mason, Fiona McKay, Kitty Lo, Christopher Boustred, Lucy Jenkins, Lyn S Chitty.- Part III\u00a0 \u00a0BIOLOGY OF CNAPS.- 15 Comparative Analysis of Harmful Physical Factors Effects on the Genome of the Cell Irina N. Vasilyeva, Valery N. Zinkin, Vladimir G. Bespalov.- 16 Heterochromatic Tandem Repeats in the Extracellular DNA Olga I. Podgornaya, Irina N. Vasilyeva, Vladimir G. Bespalov.- 17 A Historical and Evolutionary Perspective on Circulating Nucleic Acids and Extracellular Vesicles: Circulating Nucleic Acids as Homeostatic Genetic Entities Janine Aucamp, Abel J Bronkhorst. Piet J Pretorius .- 18 Comparison of microRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected microRNAs Eva Pazourkova, Sarka Pospisilova, Iveta Svobodova, Ales Horinek, Antonin Brisuda, Viktor Soukup,Jan Hrbacek, Otakar Capoun, Jaroslav Mares, Tomas Hanus, Marek Babjuk, Marie Korabecna.- 19 A Quantitative Assessment of Cell-free DNA Utilizing Several Housekeeping Genes: Measurements from Four Different Cell Lines Janine Aucamp, Abel Bronkhorst, Johannes F. Wentzel , Piet Pretorius.- 20 Oligodeoxynucleotide Analogues of Circulating DNA Inhibit dsRNA-induced Immune Response at the Early Stages of Signal Transduction Cascade in a Cell Type-dependent Manner Anna V. Cherepanova, Zhanna K. Nazarkina, Pavel P. Laktionov.- 21 GC-rich DNA Fragments and Oxidized Cell-free DNA Have Different Effects on NF-kB and NRF2 Signaling in MSC \u00a0Vasilina A. Sergeeva, Svetlana V. Kostyuk, Elizaveta S. Ershova, Elena M. Malinovskaya, Tatiana D. Smirnova, Larisa V. Kameneva, Natalia N. Veiko.- 22 Evaluation of the State of Transplanted Liver health by Monitoring of Organ-specific genomic Marker in Circulating DNA from Receptor Hada C. Macher, Gonzalo Su\u00e1rez-Artacho, Pilar Jim\u00e9nez-Arriscado, Sara \u00c1lvarez-G\u00f3mez, Noelia Garc\u00eda-Fern\u00e1ndez, Juan M. Guerrero, Patrocinio Molinero, Elena Trujillo-Arribas , Miguel A. G\u00f3mez-Bravo, Amalia Rubio.- 23 Vesicular and extra-vesicular RNAs of Human Blood Plasma Anna V. Savelyeva, Dmitriy N. Baryakin, Elena D. Chikova, Elena V. Kuligina, Vladimir A. Richter, Dmitriy V. Semenov.- 24 Artificial Analogues of Circulating Box C\/D RNAs Induce strong Innate Immune Response and microRNA Activation in Human Adenocarcinoma CellsGrigory A. Stepanov, Julia A. Filippova, Anna A. Nushtaeva, Elena V. Kuligina, Olga A. Koval, Vladimir A. Richter, and Dmitriy V. Semenov.-25 Multiple Ways of cfDNA Reception and Following ROS Production in Endothelial Cells\u00a0Anna Y. Alekseeva, Larisa V. Kameneva, Svetlana V. Kostyuk and Natalia N. Veiko.- 26 Protein Content of Circulating Nucleoprotein ComplexesSvetlana N. Tamkovich,, Oleg S. Tutanov, Danil S. Serdukov, Maxim S. Belenikin, Anatoliy G. Shlikht, Natalia A. Kirushina, Tatiana G. Duzhak, Vladimir E. Voytsitskiy, Yuri P. Tsentalovich, Pavel P. Laktionov.- Part IV Methodology.- 27 Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNAHongdo Do, Daniel Cameron, Ramyar Molania Bibhusal Thapa, Gareth Rivalland, Paul L Mitchell, Carmel Murone, Thomas John, Tony Papenfuss, Alexander Dobrovic.- 28 MFast-SeqS as a Monitoring and Prescreening Tool for Tumour-specific Aneuploidy in Plasma DNA\u00a0Methodological Variables in the Analysis of Cell-free DNA Jelena Belic, Marina Koch, Peter Ulz, Martina Auer, Teresa Gerhalter, Sumitra Mohan, Katja Fischereder, Edgar Petru, Thomas Bauernhofer5, Jochen B. Geigl, Michael R. Speicher, Ellen Heitzer.- 29 Methodological Variables in the Analysis of Cell-free DNA\u00a0Abel J. Bronkhorst, Janine Aucamp, Piet J. Pretorius .- 30 Novel Technology for Enrichment of\u00a0 Biomolecules from Cell-Free Body Fluids and Subsequent DNA Sizing Vipulkumar Patel, Peter Celec, Magdalena Grunt, Heidi Schwarzenbach, Ingo Jenneckens, Timo Hillebrand.- 31 A Rapid and Sensitive Method for Detection of the T790M Mutation of EGFR in Plasma DNA Hideharu Kimura, Shingo Nishikawa, Hayato Koba, Taro Yoneda, Takashi Sone, Kazuo Kashara.- 32 Evaluation of Different Blood Collection Tubes and Blood Storage Conditions for the Preservation and Stability of Cell-free Circulating DNA for the Analysis of the Methylated mSEPT9 Colorectal Cancer Screening Marker Jurgen Distler, ReimoTetzner, Gunter Weiss, Thomas K\u00f6nig, Anne Schlegel, Michal Bagrowski.- 33 Purification of Circulating Cell-Free DNA from Plasma and Urine Using the Automated Large-Volume Extraction on the QIAsymphony SP Instrument Alexander Wolf, Katharina Beller, Sebastian Groemminger, Wera Hofmann, Matthias Sachse, Jana Fassunke.- 34 Detection and Quantification of KIT mutations in ctDNA by Plasma Safe-SeqS Johannes Fredebohm, Daniel Mehnert, Ann-Kathrin L\u00f6ber, Frank Holtrup, Vanessa van Rahden, Philipp Angenendt, Frank Diehl.- Part V Ethics.- 35 Lost in translation? Ethical challenges of implementing a new diagnostic procedure Dagmar Schmitz.- Part VI\u00a0 Round-table.- 36 Academia meets Industry General Discussion between panel and audience.\u00a0","merchants_number":2,"ean":9783319420424,"category_id":103,"size":null,"min_price":211,"low_price_merchant_id":70255345,"ID":4174511,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"circulating-nucleic-acids-in-serum-and-plasma-cnaps-ix","url":"\/unterhaltung\/produkt\/circulating-nucleic-acids-in-serum-and-plasma-cnaps-ix\/","low_price_merchant_name":"eUniverse"}
Produkt merken zur Merkliste CHF 239.00
Dermatopathology A-Z
Table of ContentsPart IAChapter 1AbscessChapter 2AcanthamoebiasisChapter 3Acantholytic AcanthomaChapter 4Acanthosis NigricansChapter 5Accessory TragusChapter 6Acne AgminataChapter 7Acne ConglobataChapter 8Acne FulminansChapter 9Acne Keloidalis NuchaeChapter 10Acne VulgarisChapter 11Acral FibrokeratomaChapter 12Acral FibromyxomaChapter 13Acral Persistent Papular MucinosisChapter 14Acro... zur Produkt-Seite
5024900 {"price-changing":0,"image":"https:\/\/image.vergleiche.ch\/small\/aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZGUvYTYvNTAvNjg5Njg0MDMwMDAwMUFfNjAweDYwMC5qcGc=!aHR0cHM6Ly9vczEubWVpbmVjbG91ZC5pby9iMTAxNTgvbWVkaWEvaW1hZ2UvZGUvYTYvNTAvNjg5Njg0MDMwMDAwMUFfNjAweDYwMC5qcGd8fnxodHRwczovL2kud2VsdGJpbGQuZGUvcC9kZXJtYXRvcGF0aG9sb2d5LWEtei0zMjc5MDgwNTIuanBn","post_title":"Dermatopathology A-Z","deeplink":"https:\/\/cct.connects.ch\/tc.php?t=116298C1969900829T&subid=9783319894850&deepurl=https%3A%2F%2Feuniverse.ch%2Fbuecher%2Fmathematik-naturwissenschaft-technik%2Fmedizin-pharmazie%2F475554%2Fdermatopathology-a-z-a-comprehensive-guide%3FsPartner%3Dtoppreise","labels":[],"brand_id":1,"post_content":"Table of ContentsPart IAChapter 1AbscessChapter 2AcanthamoebiasisChapter 3Acantholytic AcanthomaChapter 4Acanthosis NigricansChapter 5Accessory TragusChapter 6Acne AgminataChapter 7Acne ConglobataChapter 8Acne FulminansChapter 9Acne Keloidalis NuchaeChapter 10Acne VulgarisChapter 11Acral FibrokeratomaChapter 12Acral FibromyxomaChapter 13Acral Persistent Papular MucinosisChapter 14AcroangiodermatitisChapter 15AcrochordonChapter 16Acrodermatitis Chronica AtrophicansChapter 17Acrokeratosis Verruciformis of HopfChapter 18AcrospiromaChapter 19Actinic CheilitisChapter 20Actinic GranulomaChapter 21Actinic KeratosisChapter 22Actinic PrurigoChapter 23Actinic ReticuloidChapter 24ActinomycosisChapter 25Acute Generalized Exanthematous PustulosisChapter 26Acute Lupus ErythematosusChapter 27Adenoid Cystic CarcinomaChapter 28Adult T-Cell Lymphoma \/ LeukemiaChapter 29African Tick BiteChapter 30Aggressive Digital Papillary AdenocarcinomaChapter 31AlbinismChapter 32Allergic Contact DermatitisChapter 33Alopecia AreataChapter 34Alpha-1 Antitrypsin PanniculitisChapter 35AlternariosisChapter 36Amalgam TattooChapter 37AmeloblastomaChapter 38AmyloidosisChapter 39Androgenic AlopeciaChapter 40AnetodermaChapter 41AngiofibromaChapter 42AngiokeratomaChapter 43AngioleiomyomaChapter 44AngiolipomaChapter 45Angiolymphoid Hyperplasia with EosinophiliaChapter 46AngiomatosisChapter 47AngiomyofibroblastomaChapter 48AngiomyolipomaChapter 49AngiomyxomaChapter 50AngiosarcomaChapter 51Aplasia CutisChapter 52Apocrine AdenocarcinomaChapter 53Apocrine Papillary CystadenomaChapter 54ArgyriaChapter 55Arteriovenous HemangiomaChapter 56Arteriovenous MalformationChapter 57Arthropod BiteChapter 58AspergillosisChapter 59Asteatotic DermatitisChapter 60Atopic DermatitisChapter 61Atrophie BlancheChapter 62Atrophoderma of Pasini and PieriniChapter 63Atypical FibroxanthomaChapter 64Atypical Mycobacterial InfectionChapter 65Axillary Granular ParakeratosisPart IIBChapter 66Bacillary AngiomatosisChapter 67Balloon Cell NevusChapter 68Basal Cell CarcinomaChapter 69Basaloid Follicular HamartomaChapter 70Becker's NevusChapter 71Bednar's TumorChapter 72Beh et's DiseaseChapter 73BlastomycosisChapter 74Blastomycosis-like PyodermaChapter 75Blue NevusChapter 76BotryomycosisChapter 77Bowen's DiseaseChapter 78Bowenoid PapulosisChapter 79Branchial Cleft CystChapter 80Bronchogenic CystChapter 81Bullosis DiabeticorumChapter 82Bullous Lupus ErythematosusChapter 83Bullous PemphigoidChapter 84BurnPart IIICChapter 85Caf\u00e9 au Lait MaculesChapter 86Calcifying (Juvenile) Aponeurotic FibromaChapter 87Calcinosis Cutis\u00a0Chapter 88CalciphylaxisChapter 89CallusChapter 90CandidiasisChapter 91Capillary HemangiomaChapter 92CarcinosarcomaChapter 93Cat Scratch DiseaseChapter 94Cavernous HemangiomaChapter 95Cellular Blue NevusChapter 96Cellular Digital FibromaChapter 97CellulitisChapter 98ChalazionChapter 99ChancroidChapter 100Cherry AngiomaChapter 101Chondroid SyringomaChapter 102Chondrodermatitis Nodularis HelicisChapter 103ChondromaChapter 104ChondrosarcomaChapter 105ChordomaChapter 106ChromoblastomycosisChapter 107ChrysiasisChapter 108Churg Strauss DiseaseChapter 109Cicatricial PemphigoidChapter 110Ciliated CystChapter 111Circumscribed Acral HypokeratosisChapter 112ClavusChapter 113Clear Cell AcanthomaChapter 114Clear Cell SarcomaChapter 115CoccidioidomycosisChapter 116Cold PanniculitisChapter 117CollagenomaChapter 118Collagenous and Elastotic Plaques of the HandsChapter 119Collision TumorChapter 120Colloid MiliumChapter 121Coma BlisterChapter 122Combined NevusChapter 123Compound NevusChapter 124Condyloma AccuminatumChapter 125Condyloma LataChapter 126Confluent and Reticulated Papillomatosis of Gourgerout and CartoudChapter 127Congenital NevusChapter 128Connective Tissue NevusChapter 129Cranial FasciitisChapter 130Crohn's DiseaseChapter 131CryoglobulinemiaChapter 132CryptococcusChapter 133Cutaneous B-Cell LymphomaChapter 134Cutaneous HornChapter 135Cutaneous MetastasisChapter 136Cutaneous NK\/T Cell LymphomasChapter 137Cutis LaxaChapter 138CylindromaChapter 139Cylindroma MalignantChapter 140CytomegalovirusChapter 141Cytophagic Histiocytic Panniculitis\u00a0Part IVDChapter 142Darier's DiseaseChapter 143Deep Penetrating NevusChapter 144Degos DiseaseChapter 145Dermal Duct TumorChapter 146Dermal MelanocytosisChapter 147Dermal NevusChapter 148Dermatitis HerpetiformisChapter 149DermatofibromaChapter 150Dermatofibrosarcoma Protuberans\u00a0Chapter 151DermatomyositisChapter 152DermatomyofibromaChapter 153Dermatosis Papulosa NigraChapter 154Dermoid CystChapter 155Digital Mucous CystChapter 156Dilated Pore of WinerChapter 157Discoid Lupus ErythematosusChapter 158Dissecting CellulitisChapter 159Dowling Degos DiseaseChapter 160Drug ReactionChapter 161Ductal Eccrine AdenocarcinomaChapter 162Dyshidrotic DermatitisChapter 163Dysplastic NevusPart VEChapter 164EcthymaChapter 165Ecthyma GangrenosumChapter 166ElastofibromaChapter 167ElastomaChapter 168Elastosis Perforans SerpiginosaChapter 169Electrocautery\/Electrodessication ArtifactChapter 170Encapsulated and Palisaded NeuromaChapter 171EndometriosisChapter 172EnterobiasisChapter 173Eosinophilic FasciitisChapter 174Eosinophilic FolliculitisChapter 175Eosinophilic PanniculitisChapter 176EphelisChapter 177Epidermal Inclusion CystChapter 178Epidermal NevusChapter 179Epidermodysplasia VerruciformisChapter 180Epidermolysis Bullosa Acquisita \/ SimplexChapter 181Epidermolytic Acanthoma \/ HyperkeratosisChapter 182Epulis FissuratumChapter 183ErysipelasChapter 184Erythema Ab IgneChapter 185Erythema Annulare CentrifugumChapter 186Erythema Chronicum MigransChapter 187Erythema Dischromicum PerstansChapter 188Erythema Elevatum DiutinumChapter 189Erythema InduratumChapter 190Erythema MarginatumChapter 191Erythema MultiformeChapter 192Erythema NodosumChapter 193Erythema Nodosum LeprosumChapter 194Erythema Toxicum NeonatorumChapter 195ErythrasmaChapter 196Extramammary FibroadenomaChapter 197Extranodal NK\/T-Cell Lymphoma, Nasal TypeChapter 198Extrarenal Malignant Rhabdoid TumorPart VIFChapter 199Factitial Dermatititis\/PanniculitisChapter 200Fibroblastic Connective Tissue NevusChapter 201Fibroepithelioma of PinkusChapter 202FibrofolliculomaChapter 203Fibroma of Tendon SheathChapter 204FibromatosisChapter 205Fibro-Osseous Pseudotumor of the DigitsChapter 206FibrosarcomaChapter 207Fibrous Hamartoma of InfancyChapter 208Fixed Drug ReactionChapter 209Focal Dermal MucinosisChapter 210Focal Dermal HypoplasiaChapter 211Follicular EczemaChapter 212Follicular MucinosisChapter 213Folliculosebaceous Cystic HamartomaChapter 214Folliculitis - AcuteChapter 215Folliculitis - BacterialChapter 216Folliculitis DecalvansChapter 217Folliculitis - DemodexChapter 218Folliculitis - FungalChapter 219Folliculitis - HerpeticChapter 220Folliculitis - PityrosporumChapter 221Foreign Body ReactionChapter 222Fox-Fordyce DiseaseChapter 223Freeze ArtifactChapter 224Friction BlisterChapter 225FusariosisPart VIIGChapter 226Galli-Galli DiseaseChapter 227GauzeChapter 228GelfoamChapter 229Generalized Eruptive HistiocytosisChapter 230Giant Cell Tumor of Tendon SheathChapter 231Glomeruloid HemangiomaChapter 232GlomangiomaChapter 233Glomus TumorChapter 234Gottron's PapuleChapter 235GoutChapter 236Graft-Versus-Host DiseaseChapter 237Granular Cell TumorChapter 238Granulation TissueChapter 239Granuloma AnnulareChapter 240Granuloma FacialeChapter 241Granuloma InguinaleChapter 242Grover's DiseaseChapter 243GynecomastiaPart VIIIHChapter 244Hailey-Hailey DiseaseChapter 245Halo NevusChapter 246HalogenodermaChapter 247Hand Foot and Mouth DiseaseChapter 248HemangioendotheliomaChapter 249HemangiomaChapter 250HemangiopericytomaChapter 251Henoch-Sch\u00f6nlein PurpuraChapter 252Herpes GestationisChapter 253Herpes VirusChapter 254Heterotopic Neural TissueChapter 255HibernomaChapter 256Hidradenoma PapilliferumChapter 257Hidroacanthoma SimplexChapter 258Hidradenitis SuppurativaChapter 259HidrocystomaChapter 260HistoplasmosisChapter 261Hobnail HemangiomaChapter 262Hodgkin's DiseaseChapter 263Hyalinosis Cutis et MucosaeChapter 264Hybrid CystChapter 265Hydroa VacciniformeChapter 266Hypertrophic ScarPart IXIChapter 267Ichthyosis \/ KeratodermaChapter 268Id ReactionChapter 269IgA PemphigusChapter 270Incontinencia PigmentiChapter 271Infantile AcropustulosisChapter 272Infantile Digital FibromatosisChapter 273Inflammatory Linear Verrucous Epidermal NevusChapter 274Intravascular Large B-Cell LymphomaChapter 275Intravascular Papillary Endothelial HyperplasiaChapter 276Inverted Follicular KeratosisChapter 277ImpetigoChapter 278Irritant Contact DermatitisChapter 279Ischemic FasciitisPart XJChapter 280Jessner's Lymphocytic InfiltrateChapter 281Junctional NevusChapter 282Juvenile Hyaline FibromatosisPart XIKChapter 283Kaposi's SarcomaChapter 284Kaposiform HemagioendotheliomaChapter 285KeloidChapter 286Keratin GranulomaChapter 287KeratoacanthomaChapter 288Keratosis PilarisChapter 289Kimura's DiseaseChapter 290Knuckle PadChapter 291Kyrle's DiseasePart XIILChapter 292Langerhans Cell HistiocytosisChapter 293Large Cell AcanthomaChapter 294Larva MigransChapter 295LeiomyomaChapter 296LeiomyosarcomaChapter 297LeishmaniasisChapter 298Lentigo SimplexChapter 299Leukemia CutisChapter 300Leukocytoclastic VasculitisChapter 301LeukoedemaChapter 302LeukoplakiaChapter 303Leprosy-LepromatousChapter 304Leprosy-TuberculoidChapter 305Lichen AureusChapter 306Lichen MyxedematosusChapter 307Lichen NitidusChapter 308Lichen PlanopilarisChapter 309Lichen PlanusChapter 310Lichen Planus-Like KeratosisChapter 311Lichen Sclerosus et AtrophicusChapter 312Lichen Simplex ChronicusChapter 313Lichen StriatusChapter 314Light ReactionChapter 315Linear IgA Bullous DermatosisChapter 316LipodermatosclerosisChapter 317LipomaChapter 318LiposarcomaChapter 319Livedo ReticularisChapter 320LobomycosisChapter 321Low Grade Fibromyxoid SarcomaChapter 322Lupus ErythematosusChapter 323Lupus PanniculitisChapter 324Lupus PernioChapter 325Lyme DiseaseChapter 326LymphadenomaChapter 327LymphangiomaChapter 328LymphedemaChapter 329Lymphoepithelioma-Like CarcinomaChapter 330Lymphogranuloma VenereumChapter 331Lymphomatoid PapulosisPart XIIIMChapter 332Majocchi's GranulomaChapter 333MalakoplakiaChapter 334Malignant Fibrous HistiocytomaChapter 335Malignant Peripheral Nerve Sheath TumorChapter 336Mastocytosis - SystemicChapter 337Median Raphe CystChapter 338MelanoacanthomaChapter 339Melanocytic MatricomaChapter 340MelanomaChapter 341Merkel Cell CarcinomaChapter 342Meyerson's NevusChapter 343Microcystic Adnexal Carcinoma (MAC)Chapter 344Microscopic PolyangiitisChapter 345Migratory GlossitisChapter 346MiliariaChapter 347MiliaChapter 348MinocyclineChapter 349Molluscum ContagiosumChapter 350Mongolian SpotChapter 351Monsel's Solution ReactionChapter 352Montgomery's TubercleChapter 353Morphea \/ SclerodermaChapter 354MucinosesChapter 355Mucinous CarcinomaChapter 356MucoceleChapter 357Mucoepidermoid CarcinomaChapter 358MucormycosisChapter 359Mucosal LentigoChapter 360Multinucleated Cell AngiohistiocytomaChapter 361MycetomaChapter 362Mycosis FungoidesChapter 363MyiasisChapter 364MyoepitheliomaChapter 365MyofibromaChapter 366MyxomaPart XIVNChapter 367Necrobiosis LipoidicaChapter 368Necrobiotic XanthogranulomaChapter 369Necrolytic Migratory ErythemaChapter 370Necrotizing FasciitisChapter 371Necrotizing SialometaplasiaChapter 372Nephrogenic Systemic FibrosisChapter 373NeurofibromaChapter 374Neurofollicular HamartomaChapter 375NeurothekeomaChapter 376Neutrophilic Eccrine HidradenitisChapter 377Nevus ComedonicusChapter 378Nevus DepigmentosusChapter 379Nevus FlammeusChapter 380Nevus LipomatosusChapter 381Nevus of Ito\/Ota\/Hori\/SunChapter 382Nevus Sebaceus of JadassohnChapter 383Nevus SpilusChapter 384Nipple AdenomaChapter 385NocardiosisChapter 386Nodular FasciitisChapter 387Non-Langerhans Cell Histiocytosis of Skin and MucosaChapter 388Nummular DermatitisPart XVOChapter 389OchronosisChapter 390Omphalomesenteric Duct RemnantChapter 391OnchocerciasisChapter 392OnychomycosisChapter 393OnychomatricomaChapter 394Oral FibromaChapter 395Oral Hairy LeukoplakiaChapter 396OrfChapter 397Orofacial GranulomatosisChapter 398Ossifying Fibromyxoid TumorChapter 399OsteomaChapter 400Osteo-Nevus of NantaChapter 401OsteosarcomaPart XVIPChapter 402Paget's DiseaseChapter 403Pagetoid ReticulosisChapter 404Palisaded Neutrophilic and Granulomatous DermatitisChapter 405Pancreatic PanniculitisChapter 406Papillary Eccrine AdenomaChapter 407Papular Acrodermatitis of ChildhoodChapter 408Papular MucinosisChapter 409ParacoccidioidomycosisChapter 410ParaffinomaChapter 411Paraneoplastic PemphigusChapter 412ParapsoriasisChapter 413PEComaChapter 414PediculosisChapter 415Pemphigus FoliaceousChapter 416Pemphigus VegetansChapter 417Pemphigus VulgarisChapter 418Penicillamine DermopathyChapter 419Perforating CollagenosisChapter 420Perforating DermatosisChapter 421Perforating FolliculitisChapter 422Perifollicular FibromaChapter 423PerineuriomaChapter 424Perioral DermatitisChapter 425PerniosisChapter 426PhaeohyphomycosisChapter 427Photoallergic DermatitisChapter 428Phototoxic DermatitisChapter 429Pigmented Follicular CystChapter 430Pigmented Purpuric DermatosesChapter 431Pigmented Spindle Cell Nevus of ReedChapter 432Pilar CystChapter 433Pilar Sheath AcanthomaChapter 434PilomatricomaChapter 435Pilomatrix CarcinomaChapter 436Pilonidal SinusChapter 437Pitted KeratolysisChapter 438Pityriasis AlbaChapter 439Pityriasis AmiantaceaChapter 440Pityriasis Lichenoides et Varioliformis AcutaChapter 441Pityriasis Lichenoides ChronicaChapter 442Pityriasis RoseaChapter 443Pityriasis Rubra PilarisChapter 444Pityriasis VersicolorChapter 445PlasmacytomaChapter 446Pleomorphic FibromaChapter 447PoikilodermaChapter 448Polyarteritis NodosaChapter 449Polymorphous Light EruptionChapter 450PorocarcinomaChapter 451PoromaChapter 452PorokeratosisChapter 453PorphyriaChapter 454Postinflammatory Pigment AlterationChapter 455Pretibial MyxedemaChapter 456Primary Cutaneous Anaplastic Large Cell T-Cell LymphomaChapter 457Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg TypeChapter 458Primary Cutaneous Follicle Center LymphomaChapter 459Primary Cutaneous Mantle Cell LymphomaChapter 460Primary Cutaneous Marginal Zone LymphomaChapter 461Proliferating Epidermal Inclusion CystChapter 462Proliferating Pilar CystChapter 463Progressive Nodular HistiocytosisChapter 464ProtothecosisChapter 465Prurigo NodularisChapter 466Pruritic Papules of HIVChapter 467Pruritic Urticarial Papules and Plaques of PregnancyChapter 468Pseudocyst of AuricleChapter 469PseudolymphomaChapter 470Pseudopelade of BrocqChapter 471PseudoporhyriaChapter 472Pseudoxanthoma ElasticumChapter 473PsoriasisChapter 474Purpura FulminansChapter 475Purpura SenilisChapter 476Pyoderma FacialeChapter 477Pyoderma GangrenosumChapter 478Pyogenic GranulomaPart XVIIRChapter 479Radiation DermatitisChapter 480Recurrent NevusChapter 481Relapsing PolychondritisChapter 482Reticular Erythematous MucinosisChapter 483ReticulohistiocytomaChapter 484RhabdomyomaChapter 485RhabdomyosarcomaChapter 486Rheumatoid NoduleChapter 487RhinophymaChapter 488RhinoscleromaChapter 489RhinosporidiosisChapter 490RosaceaChapter 491Rosai Dorfman DiseasePart XVIIISChapter 492SarcoidosisChapter 493ScabiesChapter 494ScarChapter 495Scarring AlopeciaChapter 496ScleredemaChapter 497Sclerema NeonatorumChapter 498ScleromyxedemaChapter 499Sclerotic FibromaChapter 500SchistosomiasisChapter 501SchwannomaChapter 502SebaceomaChapter 503Sebaceous AdenomaChapter 504Sebaceous CarcinomaChapter 505Sebaceous HyperplasiaChapter 506Seborrheic DermatitisChapter 507Seborrheic KeratosisChapter 508Solar ElastosisChapter 509Solar LentigoChapter 510Special Site NevusChapter 511Spider AngiomaChapter 512SpiradenomaChapter 513SpiradenocarcinomaChapter 514Spitz NevusChapter 515SplinterChapter 516SporotrichosisChapter 517Squamous Cell CarcinomaChapter 518Staphylococcal Scalded Skin SyndromeChapter 519SteatocystomaChapter 520Striae DistansaeChapter 521StrongyloidiasisChapter 522Stucco KeratosisChapter 523Subacute Cutaneous Lupus ErythematosusChapter 524Subcorneal Neutrophilic PustulosisChapter 525Subcutaneous Fat Necrosis of the NewbornChapter 526Subcutaneous Panniculitis-Like T-Cell LymphomaChapter 527SunburnChapter 528Supernumerary DigitChapter 529Supernumerary NippleChapter 530Suture GranulomaChapter 531Sweet's SyndromeChapter 532Synovial CystChapter 533SyphilisChapter 534Syringocystadenoma PapilliferumChapter 535SyringofibroadenomaChapter 536SyringomaPart XIXTChapter 537Takayasu ArteritisChapter 538Talon NoirChapter 539TattooChapter 540TelangiectasiasChapter 541Telangiectasia Macularis Eruptiva PerstansChapter 542Telogen EffluviumChapter 543Temporal ArteritisChapter 544TickChapter 545TineaChapter 546Tinea NigraChapter 547Thromboangiitis ObliteransChapter 548ThrombophlebitisChapter 549Thymic CystChapter 550Thyroglossal CystChapter 551Toxic Epidermal NecrolysisChapter 552Traction Alopecia \/ Pressure AlopeciaChapter 553Transient Neonatal Pustular MelanosisChapter 554Traumatic Fat NecrosisChapter 555Traumatic Neuroma \/ Amputation NeuromaChapter 556Traumatic Neuroma \/ Rudimentary DigitChapter 557Trichilemmal CarcinomaChapter 558TrichilemmomaChapter 559Trichilemmoma DesmoplasticChapter 560Trichoadenoma of NikolowskiChapter 561TrichoblastomaChapter 562TrichodiscomaChapter 563TrichoepitheliomaChapter 564Trichoepithelioma DesmoplasticChapter 565TrichofolliculomaChapter 566TrichogerminomaChapter 567Trichostasis SpinulosaChapter 568TrichotillomaniaChapter 569TuberculosisChapter 570Tubular Apocrine AdenomaChapter 571Tufted HemangiomaChapter 572Tumid LupusChapter 573Tumor of Follicular InfundibulumChapter 574TungiasisPart XXUChapter 575Urachal CystChapter 576UrticariaChapter 577Urticarial VasculitisChapter 578Urticaria PigmentosaPart XXIVChapter 579VasculopathyChapter 580Vellus Hair CystChapter 581Venous LakeChapter 582Verruca PlanaChapter 583Verruca VulgarisChapter 584Verrucous CarcinomaChapter 585Viral ExanthemaChapter 586VitiligoPart XXIIWChapter 587Warthy DyskeratomaChapter 588Weber-Christian DiseaseChapter 589Wegener's GranulomatosisChapter 590Wells SyndromeChapter 591White Sponge NevusPart XXIIIXChapter 592XanthogranulomaChapter 593Xanthoma \/ XanthelasmaPart XXIVZChapter 594Zoon's Balanitis \/ Vulvitis","merchants_number":2,"ean":9783319894850,"category_id":103,"size":null,"min_price":239,"low_price_merchant_id":70255345,"ID":5024900,"merchants":["euniverse","weltbild"],"brand":"undefined","slug":"dermatopathology-a-z","url":"\/unterhaltung\/produkt\/dermatopathology-a-z\/","low_price_merchant_name":"eUniverse"}
undefined
National Forest Inventories
Title: National Forest Inventories - Assessment of Wood Availability and Use (467 pages)Editors: Adrian Lanz, Iciar Alberdi Asensio, Laura Hernande...
undefined
Consultation in Neurourology
Table of Contents Foreword(s) Preface Part I INTRODUCTION Chapter 1 Book Presentation with Overview of Bladder Physiology Book Prese...
undefined
The Palgrave Handbook of Intersectionality...
TABLE OF CONTENTS 1. Bringing Intersectionality to Public Policy: An IntroductionOlena Hankivsky & Julia Jordan-Zachery PART I: FOUNDATIONS IN THE...
undefined
Essentials of Clinical Mycology
REVIEWS OF FIRST EDITION:From the New England Journal of Medicine, June 24, 2004About 40 years ago, when I started seeing patients in my specialty ...
undefined
Current Management of Venous Diseases
Current Management of Venous Diseases Editor: Cassius Iyad Ochoa Chaar Table of Contents Section I: Clinical Fundamentals Chapter...
undefined
Contemporary Kidney Transplantation
Section 1. History of kidney transplantation Section 2. Recipient Selection 1. Indications and contraindications2. Evaluation and select...
undefined
Essentials of Regional Anesthesia
Table of ContentsPart I General Principles of Regional Anesthesia PracticeChapter 1 General Considerations for Regional Anesthesia Practice Svetla...
undefined
Polyamines
Preface...Table of Contents...Contributing Authors...1. Polyamines in the Context of Metabolic NetworksWegi Wuddineh, Rakesh Minocha, and Subhash C...
undefined
Management of Soft Tissue Sarcoma
Management of Soft Tissue Sarcoma Table of Contents Preface Part I Introduction 1. General Descriptio...
undefined
Psychodynamic Perspectives on Aging and Il...
Endorsements:"The Second Edition of ,Psychodynamic Perspectives on Aging and Illness ,is a timely and superb revision which offers health-c...
undefined
The Median Nerve
Introduction.- List of abbreviations.- Synoptic table.- Sensory conduction studies index (according to practical criteria).- Part 1 Sensory conduct...
undefined
You Should Test That
Foreword xxiiiIntroduction xxvChapter 1 Why You Should Test That 1Your Website Is Crucial to Your Business 2Your Website Is Underperforming 4All We...
undefined
A Consumer's Guide to Archaeological Science
Part I Basic Science.-Chapter 1 Elements, Atoms and Molecules.- Matter and the Atom.-The Periodic Table of Elements.-Chemical Bonding.-Chemical Eq...
undefined
A Chronicle of Permutation Statistical Met...
Preface.- 1.Introduction.- 2.1920-1939.- 2.1.Overview of Chapter 2.- 2.2.Neyman-Fisher-Geary and the Beginning.- 2.3.Fisher and the Variance-ratio ...
undefined
Probability and Statistics for Computer Sc...
1 Notation and conventions 9 1.0.1 Background Info...
undefined
Clinical Anesthesia
Table of Contents 1 Case 1: No Fibro-Optic Intubation System - A Potential Problem 2 Case 2: Is the Patient Extubated? 3 ...
undefined
Advances in Information Retrieval
Keynotes.- Still Haven't Found What I'm Looking For: Suggestions for Search Research.- Mining and Modeling Online Health Search.- What to do if you...
undefined
Fostering Creativity and Innovation
Table of Contents 1 1.1 Introduction to Organizational Creativity and Innovation 1.2 Challenges of Global Entr...
undefined
Circulating Nucleic Acids in Serum and Pla...
Foreword Peter B. Gahan, Michael Fleischhacker, Bernd Schmidt .- Part I Nucleic Acids in Oncology - prognosis, treatments screening and metastase...
undefined
Dermatopathology A-Z
Table of ContentsPart IAChapter 1AbscessChapter 2AcanthamoebiasisChapter 3Acantholytic AcanthomaChapter 4Acanthosis NigricansChapter 5Accessory Tra...